Page 21234..1020..»

Archive for the ‘Life Extension’ Category

Antioxidant Supplement Market 2026 Industry Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global…

The COVID-19 Outbreak:Global Antioxidant Supplement Market to witnessed good recovery in growth and projected coverup market sizing during the forecast period (2020-2026). The assessment provides a 360 view and insights outlining the key outcomes of the Antioxidant Supplement market, current scenario analysis that highlights slowdown aims to provide unique strategies and solutions following and benchmarking key players strategies. In addition, the study helps with competition insights of emerging players in understanding the companies more precisely to make better informed decisions. Some of the key players that are part of coverage are NOW, Vibrant Health, AST R-ALA, GNC, Jarrow Formulas, Life Extension.

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets

Get Free Sample Copy of This Research Report:

On the basis ofProduct, this report displays the production, revenue, price, market share and growth rate of each type:

Medical Grade, Food Grade

On the basis ofApplications, the market has been segmented into:

Medical, Food, Cosmetics

TopCompaniescovered in the report:NOW, Vibrant Health, AST R-ALA, GNC, Jarrow Formulas, Life Extension

Read Full TOC of Antioxidant Supplement Research Study at

Research Methodology:

Years considered for the study are:Historical year 2016-2019Disreputable year 2020Estimate period** 2020 to 2025 [** unless otherwise stated]

Primary Research:

The primary sources involve the industry experts from the Global Antioxidant Supplement industry including the management organizations, processing organizations, analytics service providers of the industrys value chain. All primary sources were interviewed to gather and authenticate qualitative & quantitative information and determine the future prospects.In the extensive primary research process undertaken for this study, the primary sources industry experts such as CEOs, vice presidents, marketing director, technology & innovation directors, founders and related key executives from various key companies and organizations in the Global Antioxidant Supplement industry have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

Secondary Research:

In the Secondary research crucial information about the industries value chain, total pool of key players, and application areas. It also assisted in market segmentation according to industry trends to the bottom-most level, geographical markets and key developments from both market and technology-oriented perspectives.

Table of ContentsGlobal Antioxidant Supplement Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

1 Antioxidant Supplement Market Overview1.1 Introduction1.2 Scope1.3 Assumptions1.4 Players Covered1.5 Market Analysis By Type1.5.1 Global Antioxidant Supplement Market Size Growth Rate By Type (2020-2025)1.5.2 1.5.3 1.5.4 1.6 Market By Application1.6.1 Global Antioxidant Supplement Market Share By Application (2020-2025)1.6.2 Application I1.6.3 Application Ii1.6.4 1.7 Study Objectives1.8 Years

2 Executive Summary

3 Antioxidant Supplement Market Analysis By Type (Historic 2016-2019)3.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-20193.1.1 Type I3.1.2 Type Ii3.1.3 Type Iii3.2 Global Antioxidant Supplement Market Share Analysis By Type (%) 2016-2019

4 Antioxidant Supplement Market Analysis By Application (Historic 2016-2019)4.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-2019

5 Antioxidant Supplement Market Analysis By Regions (Historic 2016-2019)5.1 Global Antioxidant Supplement Market Size Analysis (USD Million) 2016-20195.1.1 Antioxidant Supplement Market Share By Regions (2016-2019)5.1.2 United States5.1.3 Europe5.1.4 China5.1.5 Japan5.1.6 India5.1.7 Rest Of The World

6 Key Companies Analysis/Company Profile


Buy the Up-to-date Full Report

Key Questions Answered by Antioxidant Supplement Market Report

1. What was the Antioxidant Supplement Market size in 2018 and 2019; what are the estimated growth trends and market forecast (2020-2025).2. What will be the CAGR of Antioxidant Supplement Market during the forecast period (2020-2025)?3. Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are expected to grow during the forecast period (2020-2025).4. Which manufacturer/vendor/players in the Data Management Platform Market was the market leader in 2019?5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.

Enquire for Discount in Report*Get Upto $1000 Flat Discount on All License Type.

About UsWe at Read offers wide range of business services including but not limited to Market Research, Syndicate and Custom Research, Company Research, Business Consulting, Audit & Risk, Communications, Finance, Information Technology, Legal & Compliance, Human Resources and Sales.

Contact:Read Market ResearchDev Dixit (Sales Manager)B-51 CMPDI, Korba, ChhattisgarhPhone: +1 646 583 1932Email:[emailprotected]Web:https://www.readmarketresearch.comFollow Us on:LinkedIN

Go here to read the rest:
Antioxidant Supplement Market 2026 Industry Trends, Size, Growth Insight, Share, Emerging Technologies, Share, Competitive, Regional, And Global...

Impact Of Covid 19 On Bilberry Extract Products Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026 – TechnoWeekly

Overview for Bilberry Extract Products Market Helps in providing scope and definitions, Key Findings, Growth Drivers, and Various Dynamics

The Bilberry Extract Products market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The global Bilberry Extract Products market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Bilberry Extract Products market. The report focuses on well-known providers in the global Bilberry Extract Products industry, market segments, competition, and the macro environment.

Under COVID-19 Outbreak, how the Bilberry Extract Products Industry will develop is also analyzed in detail in Chapter 1.7 of the report., In Chapter 2.4, we analyzed industry trends in the context of COVID-19., In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets., In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries., In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Download PDF Sample of Bilberry Extract Products Market report @

Key players in the global Bilberry Extract Products market covered in Chapter 4:, Natrol Vitamins & Supplements, Nutraceutical, Nutrilite, Life Extension, Spring Valley, Kanbo Natural Health Food, Natures Way Products, LLC., Puritans Pride, Source Naturals, Inc., Biofinest, Now foods, Ahana Nutrition, GNC, Bluebonnet Nutrition, Swanson

In Chapter 11 and 13.3, on the basis of types, the Bilberry Extract Products market from 2015 to 2026 is primarily split into:, Tablets, Cheweables, Others

In Chapter 12 and 13.4, on the basis of applications, the Bilberry Extract Products market from 2015 to 2026 covers:, E-commerce, Medical Institutions, Supermarket


Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:, North America (Covered in Chapter 6 and 13), United States, Canada, Mexico, Europe (Covered in Chapter 7 and 13), Germany, UK, France, Italy, Spain, Russia, Others, Asia-Pacific (Covered in Chapter 8 and 13), China, Japan, South Korea, Australia, India, Southeast Asia, Others, Middle East and Africa (Covered in Chapter 9 and 13), Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Others, South America (Covered in Chapter 10 and 13), Brazil, Argentina, Columbia, Chile, Others

Years considered for this report:, Historical Years: 2015-2019, Base Year: 2019, Estimated Year: 2020, Forecast Period: 2020-2026

Some Point of Table of Content:

Chapter One: Report Overview

Chapter Two: Global Market Growth Trends

Chapter Three: Value Chain of Bilberry Extract Products Market

Chapter Four: Players Profiles

Chapter Five: Global Bilberry Extract Products Market Analysis by Regions


Chapter Six: North America Bilberry Extract Products Market Analysis by Countries

Chapter Seven: Europe Bilberry Extract Products Market Analysis by Countries

Chapter Eight: Asia-Pacific Bilberry Extract Products Market Analysis by Countries

Chapter Nine: Middle East and Africa Bilberry Extract Products Market Analysis by Countries

Chapter Ten: South America Bilberry Extract Products Market Analysis by Countries

Chapter Eleven: Global Bilberry Extract Products Market Segment by Types

Chapter Twelve: Global Bilberry Extract Products Market Segment by Applications12.1 Global Bilberry Extract Products Sales, Revenue and Market Share by Applications (2015-2020)12.1.1 Global Bilberry Extract Products Sales and Market Share by Applications (2015-2020)12.1.2 Global Bilberry Extract Products Revenue and Market Share by Applications (2015-2020)12.2 E-commerce Sales, Revenue and Growth Rate (2015-2020)12.3 Medical Institutions Sales, Revenue and Growth Rate (2015-2020)12.4 Supermarket Sales, Revenue and Growth Rate (2015-2020)

Chapter Thirteen: Bilberry Extract Products Market Forecast by Regions (2020-2026) continue

List of tablesList of Tables and FiguresTable Global Bilberry Extract Products Market Size Growth Rate by Type (2020-2026)Figure Global Bilberry Extract Products Market Share by Type in 2019 & 2026Figure Tablets FeaturesFigure Cheweables FeaturesFigure Others FeaturesTable Global Bilberry Extract Products Market Size Growth by Application (2020-2026)Figure Global Bilberry Extract Products Market Share by Application in 2019 & 2026Figure E-commerce DescriptionFigure Medical Institutions DescriptionFigure Supermarket DescriptionFigure Global COVID-19 Status OverviewTable Influence of COVID-19 Outbreak on Bilberry Extract Products Industry DevelopmentTable SWOT AnalysisFigure Porters Five Forces AnalysisFigure Global Bilberry Extract Products Market Size and Growth Rate 2015-2026Table Industry NewsTable Industry PoliciesFigure Value Chain Status of Bilberry Extract ProductsFigure Production Process of Bilberry Extract ProductsFigure Manufacturing Cost Structure of Bilberry Extract ProductsFigure Major Company Analysis (by Business Distribution Base, by Product Type)Table Downstream Major Customer Analysis (by Region)Table Natrol Vitamins & Supplements ProfileTable Natrol Vitamins & Supplements Production, Value, Price, Gross Margin 2015-2020Table Nutraceutical ProfileTable Nutraceutical Production, Value, Price, Gross Margin 2015-2020Table Nutrilite ProfileTable Nutrilite Production, Value, Price, Gross Margin 2015-2020Table Life Extension ProfileTable Life Extension Production, Value, Price, Gross Margin 2015-2020Table Spring Valley ProfileTable Spring Valley Production, Value, Price, Gross Margin 2015-2020Table Kanbo Natural Health Food ProfileTable Kanbo Natural Health Food Production, Value, Price, Gross Margin 2015-2020Table Natures Way Products, LLC. ProfileTable Natures Way Products, LLC. Production, Value, Price, Gross Margin 2015-2020Table Puritans Pride ProfileTable Puritans Pride Production, Value, Price, Gross Margin 2015-2020Table Source Naturals, Inc. ProfileTable Source Naturals, Inc. Production, Value, Price, Gross Margin 2015-2020Table Biofinest ProfileTable Biofinest Production, Value, Price, Gross Margin 2015-2020Table Now foods ProfileTable Now foods Production, Value, Price, Gross Margin 2015-2020Table Ahana Nutrition ProfileTable Ahana Nutrition Production, Value, Price, Gross Margin 2015-2020Table GNC ProfileTable GNC Production, Value, Price, Gross Margin 2015-2020Table Bluebonnet Nutrition ProfileTable Bluebonnet Nutrition Production, Value, Price, Gross Margin 2015-2020Table Swanson ProfileTable Swanson Production, Value, Price, Gross Margin 2015-2020Figure Global Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Global Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table Global Bilberry Extract Products Sales by Regions (2015-2020)Table Global Bilberry Extract Products Sales Market Share by Regions (2015-2020)Table Global Bilberry Extract Products Revenue ($) by Regions (2015-2020)Table Global Bilberry Extract Products Revenue Market Share by Regions (2015-2020)Table Global Bilberry Extract Products Revenue Market Share by Regions in 2015Table Global Bilberry Extract Products Revenue Market Share by Regions in 2019Figure North America Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Europe Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Asia-Pacific Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Middle East and Africa Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure South America Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure North America Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table North America Bilberry Extract Products Sales by Countries (2015-2020)Table North America Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure North America Bilberry Extract Products Sales Market Share by Countries in 2015Figure North America Bilberry Extract Products Sales Market Share by Countries in 2019Table North America Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table North America Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure North America Bilberry Extract Products Revenue Market Share by Countries in 2015Figure North America Bilberry Extract Products Revenue Market Share by Countries in 2019Figure United States Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Canada Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Mexico Bilberry Extract Products Sales and Growth (2015-2020)Figure Europe Bilberry Extract Products Revenue ($) Growth (2015-2020)Table Europe Bilberry Extract Products Sales by Countries (2015-2020)Table Europe Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure Europe Bilberry Extract Products Sales Market Share by Countries in 2015Figure Europe Bilberry Extract Products Sales Market Share by Countries in 2019Table Europe Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table Europe Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure Europe Bilberry Extract Products Revenue Market Share by Countries in 2015Figure Europe Bilberry Extract Products Revenue Market Share by Countries in 2019Figure Germany Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure UK Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure France Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Italy Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Spain Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Russia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Asia-Pacific Bilberry Extract Products Revenue ($) and Growth (2015-2020)Table Asia-Pacific Bilberry Extract Products Sales by Countries (2015-2020)Table Asia-Pacific Bilberry Extract Products Sales Market Share by Countries (2015-2020)Figure Asia-Pacific Bilberry Extract Products Sales Market Share by Countries in 2015Figure Asia-Pacific Bilberry Extract Products Sales Market Share by Countries in 2019Table Asia-Pacific Bilberry Extract Products Revenue ($) by Countries (2015-2020)Table Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries (2015-2020)Figure Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries in 2015Figure Asia-Pacific Bilberry Extract Products Revenue Market Share by Countries in 2019Figure China Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Japan Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure South Korea Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Australia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure India Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Southeast Asia Bilberry Extract Products Sales and Growth Rate (2015-2020)Figure Middle East and Africa Bilberry Extract Products Revenue ($) and Growth (2015-2020)continue

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:Ranjeet DengaleDirector SalesAnalytical Research Cognizance+1 (646) 403-4695, +91 90967 44448Email: [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Bilberry Extract Products :

Read the original here:
Impact Of Covid 19 On Bilberry Extract Products Market 2020 Industry Challenges Business Overview And Forecast Research Study 2026 - TechnoWeekly

Funding questions loom over the UK’s Integrated Review – Army Technology

This week, the situation surrounding the review remained in doubt, with the Secretary of State for Defence Ben Wallace telling Parliament that the government was still assessing the implications of scrapping the multi-year spending review.

MPs and experts have expressed concern that only funding the Ministry of Defence (MOD) for a year would further postpone long-awaited spending decisions and add to a black hole in the departments modernisation budget.

Before the Covid-19 coronavirus pandemic struck, the UK had planned to publish the Integrated Review alongside a comprehensive spending review which would have set the MODs budget for four years, giving it room to make spending decisions.

On Monday, Wallace told MPs: The government announced on 21 October that they will conduct a one-year spending review for 2021-22. The implications of that decision for the integrated review are currently being considered. The government will provide an update to Parliament once this has been decided.

Labours Shadow Defence Minister John Healey criticised the confusion around the state of the review, saying: Is it not the regrettable truth that the Chancellor has cut the ground from under the Defence Secretary and our British forces? The Secretary of State rightly said that previous Tory defence reviews have failed because they were never in step with the spending plans.

They were a cover for cuts, which is why our armed forces are nearly 12,000 short of the strength promised in the 2015 review; essential equipment, from new tanks to the new radar system protecting our aircraft carrier, is long overdue; and the defence budget has a 13 billion black hole. A fully-fledged, fully funded strategic defence and security review is needed now more than ever. What does he say about the failure to deliver on that?

Wallace responded saying that no one has said yet that the integrated review will be delayed or curtailed but added that the government was studying the implications a one-year spending review would have.

Critical decisions on the future of the UKs Armed Forces are wrapped up in the Integrated Review, including the future of the British Armys main battle tank and infantry fighting vehicle (IFV) modernisation programmes. The army is in the final stages of negotiating contracts for the Warrior Capability Sustainment Programme (CSP) and Challenger 2 Life Extension Programme (LEP).

The British Army introduced Challenger 2 into service in 1998, and Warrior in 1984. Decisions on both upgrade programmes would likely have to be put off if the MOD only received a one-year budget.

MP and Chair of Parliaments Defence Select Committee Tobias Ellwood told Parliament that a one-year funding settlement would make the integrated review next to meaningless.

He added: The Prime Minister gave me a direct assurance that the integrated review would not be delayed. If global Britain is an instruction and not a strapline, this review is the road map to how we advance our defence posture to support our foreign policy ambitions.

Any delay to its publication with its full spending commitments will send a poor signal to the world that we are absolutely serious about re-establishing our global credentials and could prompt questions about our justification to retain a permanent seat on the UN Security Council.

The Prime Minister and the Defence Secretary have reportedly been pushing the Treasury to commit to a multi-year spending plan for defence.

In a paper published by the Royal United Services Institute (RUSI) titled A Reckoning Postponed? The Defence Arithmetic of the Integrated Review, the thinktanks deputy director-general Malcolm Chalmers wrote that the decision to abandon the multi-year spending review had thrown the Integrated Review into disarray.

Chalmers added that for defence, this decision would mean key decisions on long-term priorities would have to be pushed back to 2021 or 2022.

Chalmers added: A multi-year CSR, combined with a government committed to a radical foreign and defence policy review, would have provided the MoD with an important opportunity to get in front of these issues in relation to these two major programmes, as in other elements of the forward programme.

Now that the government has reverted to a one-year Spending Review, it will be harder to close on the key decisions that need to be taken. There is a risk that, despite the hard work that has gone into the 2020 Integrated Review, and the MDP before it, the MOD may have to repeat the exercise with a new Integrated Review (or at least a defence element of it) in summer 2021 or 2022. Such an outcome would not be good for defence, and it is likely to be bad value for money for the taxpayer.

CBRN Decontamination Equipment

Ground-based Air Defence Systems

Practice Grenades for Military Training

See original here:
Funding questions loom over the UK's Integrated Review - Army Technology

Brookings Register | Theory: Replaceable bars could save millions – Brookings Register

BROOKINGS What if damaged precast concrete bridge columns and building beams or columns could be replaced instead of having to demolish the structure?

That is the possibility a South Dakota State University graduate student and his adviser are looking at. Kallan Hart is a first-year graduate student from Faribault, Minnesota, who earned his bachelors in civil engineering in 2019. Mostafa Tazarv is an assistant professor in the Department of Civil and Environmental Engineering within the Jerome J. Lohr College of Engineering.

Work has just begun on the project, which is largely being funded by an award from the Precast/Prestressed Concrete Institute. Hart received the $40,000 Dennis Mertz Bridge Research Fellowship for 2020-21 and became the first SDSU student to receive an award from the institute. It is to cover his tuition, fees and living expenses as well as project costs.

Supplemental funds come from the National Center for Transportation Infrastructure Durability and Life Extension.

They will undertake a two-year study within the Lohr Structures Lab on campus in cooperation with industry partner Gage Brothers Concrete, Sioux Falls.

Tazarv explained steel bars are traditionally embedded within the columns or beams of a concrete structure. However, when a catastrophic event, such an earthquake, hits the structures, those bars often yield, and sometimes buckle or fracture. When the damage is extensive, the entire structure must be demolished, he explained. Hart and Tazarv will experiment placing the bars on the outside of the bridge columns, which are the main source of resistance against earthquakes and other extreme events.

Their theory is that those bars could be replaced while leaving the structure in place and saving millions of dollars as a result.

In initial testing in the Lohr Structures lab, Tazarv said the proposed repairable precast connections were investigated through cyclic testing of four half-scale beam-column specimens detailed based on a nine-story building designed for Los Angeles, which is a high seismic region. A reference cast-in-place beam-column specimen was also included for comparison.

The test results showed the repairable precast connections can withstand more than 14 times the design level earthquake with insignificant damage and ability to be repaired afterward.

Furthermore, Tazarv found precast buildings using the repairable technology can withstand extreme earthquakes with minimal damage and repair need. Now, it is the time to test the idea on bridges.

In the next two years, Hart will develop 10 new repairable details for bridge columns, rank them based on constructability, cost and expected performance, and test the top two repairable columns, each 10-feet tall, to failure.

Hart is excited to begin the research and be selected for the award.

Assisting on work in the lab the past few months has given me new insight into the seismic applications of structural engineering, despite residing in a low-seismic zone. Hopefully, our new detailing will provide transportation departments and other bridge owners an additional design option to reduce replacement costs in the inevitable event of an earthquake in high-seismic zones while also cutting the amount of time that bridges will have to be closed to the public, Hart said.

Tazarv called Hart a smart, outstanding and hardworking student. This fellowship will provide him an opportunity to perform an innovative research and also benefit from the industry partnership planned in the project.

Read the original post:
Brookings Register | Theory: Replaceable bars could save millions - Brookings Register

Global Cryonics Technology Market 2025 Current as Well as the Future Challenges: Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR – The Think…

Introduction: Global Cryonics Technology Market, 2020-27

This in-depth research report presentation on Global Cryonics Technology market offers decisive market intelligence across multi-tier levels comprising regional, industry level, followed by further supply chain landscape.

The report is thoroughly structured to ensure ample understanding and information flow on new technological milestones, novel product expansion schemes as well as pipeline activities and investments likelihood besides regulatory developments that collectively influence a steady and robust growth trail in global Cryonics Technology market. Additional details such as consumer behavior, top stimulants as well as notable barriers that also tend to mold growth prognosis in global Cryonics Technology market.

Vendor LandscapeThe report draws references of an extensive analysis of the Cryonics Technology market, entailing crucial details about key market players, complete with a broad overview of expansion probability and expansion strategies.PraxairCellulisCryologicsCryothermKrioRusVWRThermo Fisher ScientificCustom Biogenic SystemsOregon CryonicsAlcor Life Extension FoundationOsiris CryonicsSigma-AldrichSouthern Cryonics

Available Sample Report in PDF Version along with Graphs and [emailprotected]

Unbiased research findings suggest an optimistic growth in global Cryonics Technology market securing a decent growth valuation and impressive CAGR percentage which is further anticipated to continue through the forecast span. These crucial report contents suggest that the aforementioned Cryonics Technology market is likely to overcome and emerge successfully from the pandemic constraints and echo favorable growth trajectory of the past decades.

Global Cryonics Technology Market: Type & Application based Analysis

Analysis by Type: This section of the report includes factual details pertaining to the most lucrative segment harnessing revenue maximization.Slow freezingVitrificationUltra-rapid

Analysis by Application: Further in the subsequent sections of the report, research analysts have rendered precise judgment regarding the various applications that the Cryonics Technology market mediates for superlative end-user benefits.Animal husbandryFishery scienceMedical sciencePreservation of microbiology cultureConserving plant biodiversity

Reader Centric Queries: Global Cryonics Technology Market

The report showcases a detailed overview and scenario evaluation of the global Cryonics Technology market for the period, 2020-25

Accurate CAGR predictions through the forecast tenure, 2020-25

A clear understanding and analytical review of all the dominant factors that are likely to assist and ensure steady growth trail in global Cryonics Technology market during the next five years

Growth estimations in terms of value and volume-based growth across regions as well as global scenario

Read complete report along with TOC @

COVID-19 Impact AnalysisThis intensively researched report presentation has been prepared in real time parlance, rendering substantial attention towards COVID-19 outbreak that has lately wreaked unprecedented damage across industries, stagnating growth.

The report lends attention towards evaluating the market in terms of exhaustive research in the times of COVID, as well as devising appropriate come back protocols to restore normalcy.

Decoding Regional Overview of the Cryonics Technology MarketApart from gauging into the present as well as future implications of COVID, the report is a dependable document to understand the dormant opportunities, new products and services that are likely to be more relevant in the post COVID-19 market. This section of the report therefore shares vital details and workable cues on new product profiles to help businesses revive from the COVID aftermath.

Report Deliverable: Global Cryonics Technology Market

This detailed and versatile report synopsis on global Cryonics Technology market has been prepared on the basis of thorough research studies, summation and synthesispractices after collating information from multiple sources. In essence, this Cryonics Technology market report presents data in the following categories:

Market size estimation at global and regional levels

Dominant and popular trends

A thorough analysis based on geographical expanse to identify top growth hotspots.

The report includes sections about growth probabilities that represent major disruptions.

In-depth research findings reflected in this report opine that despite the unprecedented outbreak and lingering implications of COVID-19 and its reformatory reforms reflected across industries, the immediate and future specific implications have been thoroughly classified and elaborated in the report to encourage unbiased market discretion.

Some Major TOC Points: Chapter 1. Report Overview Chapter 2. Global Growth Trends Chapter 3. Market Share by Key Players Chapter 4. Breakdown Data by Type and Application Chapter 5. Market by End Users/Application Chapter 6. COVID-19 Outbreak: Cryonics Technology Industry Impact Chapter 7. Opportunity Analysis in Covid-19 Crisis Chapter 9. Market Driving ForceAnd Many More

A dedicated chapter on COVID-19 analysis has therefore been included in this versatile report to encourage future-ready business discretion aligning with post COVID-19 market environment.

Shoot your queries at:@

Market Report Offerings in a Gist: A thorough reference of the dominant trends as well as relevant market dynamics Elaborate analysis and reference of core products and dynamic segments A thorough analysis of the competition spectrum and winning strategies of the major players COVID-19 analysis and recovery route PESTEL and SWOT analysis besides other analysis

The report has been conceived and presented in an attempt to decode notable business decisions and trends based on which a thorough evaluation spectrum has been constructed to encourage growth oriented business discretion amongst budding market participants as well as established vendors willing to ensure hassle-free growth stride despite challenges and rising competition.

About Us :

We are a team of highly professional researchers dedicated to unravel ongoing market developments. We are recognized as best in industry one stop store, offering intensively researched market-oriented information with superlative standards of impartiality and authenticity in order to rightfully influence favorable business decisions across a range of verticals. We are highly dependent on our information scavenging abilities and extremely reliant on our intuitive capabilities that lead towards novel opportunity mapping and result in profitable business models and high revenue structures.

Contact Us :

Hector CostelloSenior Manager Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas 75204, U.S.A.Phone No.: USA: +1 (972)-362-8199 | IND: +91 895 659 5155

More here:
Global Cryonics Technology Market 2025 Current as Well as the Future Challenges: Praxair, Cellulis, Cryologics, Cryotherm, KrioRus, VWR - The Think...

Black Cumin Seed Oil (COVID-19 Version) Market Insights, Forecast to 2025 | Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils…

Black Cumin Seed Oil (COVID-19 Version) Market 2020 Overview:

Reports Monitor has recently added a new report to its vast depository titled Global Black Cumin Seed Oil (COVID-19 Version) Market 2020. The report studies vital factors about theGlobal Black Cumin Seed Oil (COVID-19 Version) Marketthat are essential to be understood by existing as well as new market players. The report highlights the essential elements such as market share, profitability, production, sales, manufacturing, advertising, technological advancements, key market players, regional segmentation, and many more crucial aspects related to theGlobal Black Cumin Seed Oil (COVID-19 Version) Market.

Important factors like strategic developments, government regulations, market analysis, end users, target audience, distribution network, branding, product portfolio, market share, threats and barriers, growth drivers, latest trends in the industry are also mentioned.

TheTop Leading playersoperating in the market to Covered in this Report:Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils GmbH, Kerfoot Group, Earthoil Plantations, Life Extension, Nuverus, Omega Pharma, BioPraep& More.

Get PDFSample Reportof Black Cumin Seed Oil (COVID-19 Version) Market 2020, Click Here @

TheBlack Cumin Seed Oil (COVID-19 Version) Marketreport is segmented in the following categories:

Segmentation by product type :Food Grade, Cosmetic Grade

Segmentation by Application :Soap, Health Food, Personal Care Products (Massage Oils, Skin Care Products)

Following regions are highlighted in this report:

Understand the influence of COVID-19 on the Black Cumin Seed Oil (COVID-19 Version) Market with our analysts monitoring the situation across the globe.Get here sample analysis

The report on Global Black Cumin Seed Oil (COVID-19 Version) Market provides detailed segmentation by type, applications and regions. Each segment provides information about the production and manufacturing during the forecast period of 2015-2026. The application segment highlights the applications and operational processes of the industry. Understanding these segments will help identify the importance of the various factors aiding to the market growth.

The market research report on the Global Black Cumin Seed Oil (COVID-19 Version) market has been carefully curated after studying and observing various factors that determine the growth such as environmental, economic, social, technological and political status of the regions mentioned. Thorough analysis of the data regarding revenue, production, and manufacturers gives out a clear picture of the global scenario of the Black Cumin Seed Oil (COVID-19 Version) market. The data will also help key players and new entrants understand the potential of investments in the Global Black Cumin Seed Oil (COVID-19 Version) Market.

Avail discount while purchasing this report, Click [emailprotected]

Key features of this report are:

For More Details On this Report:

Contact UsJay MatthewsDirect: +1 513 549 5911 (U.S.)+44 203 318 2846 (U.K.)Email:[emailprotected]

Continued here:
Black Cumin Seed Oil (COVID-19 Version) Market Insights, Forecast to 2025 | Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils...

Edited Transcript of ERII.OQ earnings conference call or presentation 29-Oct-20 9:00pm GMT – Yahoo Finance

Q3 2020 Energy Recovery Inc Earnings Call San Leandro Oct 30, 2020 (Thomson StreetEvents) -- Edited Transcript of Energy Recovery Inc earnings conference call or presentation Thursday, October 29, 2020 at 9:00:00pm GMT TEXT version of Transcript ================================================================================ Corporate Participants ================================================================================ * Bob Mao * James Siccardi Energy Recovery, Inc. - VP of IR * Joshua Ballard Energy Recovery, Inc. - CFO ================================================================================ Conference Call Participants ================================================================================ * Pavel Molchanov * Ryan James Pfingst B. Riley Securities, Inc., Research Division - Associate ================================================================================ Presentation -------------------------------------------------------------------------------- Operator [1] -------------------------------------------------------------------------------- Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the Energy Recovery Third Quarter 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note this conference is being recorded. I will now turn the conference over to your host, James Siccardi, Vice President of Investor Relations for Energy Recovery. Thank you, you may begin. -------------------------------------------------------------------------------- James Siccardi, Energy Recovery, Inc. - VP of IR [2] -------------------------------------------------------------------------------- Good afternoon everyone, and welcome to Energy Recovery's 2020 third quarter earnings conference call. My name is Jim Siccardi, Vice President of Investor Relations at Energy Recovery. I'm here today with our Chairman, President and Chief Executive Officer, Bob Mao; and our Chief Financial Officer, Joshua Ballard. During today's call, we may make projections and other forward-looking statements under The Safe Harbor provisions contained in the Private Securities Litigation Reform Act of 1995 regarding future events or the future financial performance of the Company. These statements may discuss our business, economic and market outlook, the Company's ability to commercialize VorTeq, growth expectations, new products and their performance, cost, structure and business strategy. Forward-looking statements are based on information currently available to us and on management's beliefs, assumptions, estimates or projections. Forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors. We refer you to documents the Company files from time to time with the SEC, specifically the Company's Form 10-K and Form 10-Q. These documents identify important factors that could cause actual results to differ materially from those contained in our projections or forward-looking statements. All statements made during this call are made only as of today, October 29, 2020, and the Company expressly disclaims any intent or obligations to update any forward-looking statements made during this call to reflect subsequent events or circumstances, unless otherwise required by law. At this point, I would like to turn the call over to our Chairman, President and Chief Executive Officer, Bob Mao. Bob, the floor is yours. -------------------------------------------------------------------------------- Bob Mao, [3] -------------------------------------------------------------------------------- Thank you, Jim. And thank you everyone for joining us today. I want to start today's call as I did last quarter, with sincere hope that everyone listening and your families are safe and healthy. Once again, I am happy to report that the Energy Recovery team and our business remain healthy and strong. Energy Recovery is evolving well into a COVID inspired new normal, where we continue to steadily achieve growth those in our base business as well as in our new business initiatives. The disciplined finance financial and time bounded approach to our new initiatives as recorded in our last call is being strictly executed, which should translate to a greater bottom-line results and increase returns for our investors. Following the format of my previous earnings call report, I will provide you updates to our Water business and VorTeq development in our Oil & Gas business. In addition, in our last earnings call, we committed to provide more details on our intubation effort for the PX technology platform, which was started at the end of the first quarter of this year. Today, we are happy to report our one of the efforts ZLD, Zero Liquid Discharge, which has just graduated into commercialization with receipt of the first purchase order. Let's begin with our water business, which continues to be healthy and strong, riding on incredibly strong global desalination grows even amidst the COVID pandemic. This third quarter was ERII's biggest water revenue generating quarter, eclipsing last year higher quarter record by 26%. At this time, we feel competent increasing our previously projected 20% to 25% of water's revenue growth for fiscal year 2020, up to 25%. We also feel confident in increasing our 2021 growth outlook to 10% from the flat to 5% gross we communicated last quarter. Finally, adjusting desalination industry trends allows us to optimistically anticipate water revenue growth in 2022 similar to what we are achieving in 2020. The strong global seawater reverse osmosis desalination growth trend is anchored in equivalent need to provide access to clean water in many parts of the world. In addition to the basic need, three other trends are helping to grow in seawater reverse osmosis. First, the technological shifts, from inefficient thermal desalination plants for reverse osmosis is becoming the growing portion of our pipeline. Second, acceptance of private financing into desalination construction in places like Saudi Arabia, Dubai, Egypt and India is increasingly decoupling desalination projects to national fiscal budgets, which you may be susceptible to oil price increase and COVID-19. And finally, geopolitical shifts are creating an urgent strategically move for desalination in countries like Egypt, where the construction of Nile river dam in Ethiopia, to recognize Egypt's water independence. In addition to our fundamentally strong baseline seawater reverse osmosis outlook, our first incubation initiative Zero Liquid Discharge or ZLD is focused on our water business specifically with wastewater industry. In fact, we are excited to announce that we received our first commercial purchase order to our new water wastewater product from a customer in India just this last week, which is really encouraging. A global regulatory push is currently being led by China and India to implement more environmentally friendly practices in industrial wastewater treatment. Those countries are struggling less maintaining clean water sources and they are seeking to maximize the recovery of clean water and minimize the impact of wastewater disposal polluting theirs water wastes. ZLD allows for this by fully removing the harmful industrial waste from the water and reintroducing or recycling only clean water. The ZLD market is in its nascent stages. It is fragmented market and the multiple competing technologies, none of which has emerged as a dominant technology. Much like the desalination market, we believe our reverse osmosis is the upcoming solution. However, unlike desalination the pressures needed to achieve zero or minimum liquid discharge are nearly 2,000 psi or roughly double that our seawater desalination. To address this, we are using our PX technology platform to build our high pressure PX application, which we call the Ultra PX. We believe our technology has the potential to become the dominant solution in ZLD wastewater just like our legendary PX has dominated the seawater reverse osmosis market. Our preliminary ZLD market research identified existing wastewater applications of our Ultra PX. There is a potential total addressable market in China as high as $100 million, which would not include further annual growth as the market expense. We see a similar opportunity in India, where we recently received our first purchase order, and we believe that markets globally will move further toward those new and minimal discharged technology overtime as clean water becomes a more critical resource. Nowadays, it has achieved commercialization, ZLD will move out of incubation and into our water business unit. We're proud of our R&D and commercial teams and their ability to commercialize our new Ultra PX with the several months' initial incubation well below our three years project movement. ZLD should achieve and returns on investment far exceed 20% and we anticipate ultimately achieving margins at levels comparable to our base water business. Finally, we anticipate positive operating cash flow around the asset with our first purchase orders in hand. We're truly confident in the potential of our water business, as we look forward. Our business, our baseline seawater desalination business continues to enjoy a superior upswing. There's no end in sight over the next few years and we're excited about the potential of our new wastewater business efforts. We look forward to update you on both in the future. Next, we turn to our Oil & Gas business and VorTeq where I continue to view the progress we made with great pride. We have developed our production model 1.0, which was utilized during our previously reported few simulation frac with Liberty oil fuel services. However, the three hurdles we outline must to be clear before we commercialize. One, successfully complete 2 to 3 live fracs. Two, validate our customer value proposition. And three, maximize the amount of sand that can be pushed through the cartridges before repair or replacement. As I said beginning of live frac and by extension our value proposition, we are aggressively seeking to get out in live frac before year end as live frac verification is critical to establishing the VorTeq value proposition for our customers and to verify our VorTeq cartridge service spec. In addition to our ongoing dialogue with Liberty, we have taken calls from and hosted indicators for additional oilfield service companies interested in the potential use of VorTeq. We are pleased with the response companies are giving us and the willingness which they have introduced VorTeq to their own customers. We remain confident in our ability to achieve the live well requirements as outlined last quarter and quantifying our value proposition. As soon as we have achieved our first live well, we will let you know. With regard to the final hurdle, we're making solid progress in cartridge life extension and manufacturing insurance. We believe we identified a solution to achieve our cartridge life or as a minimum, a solution that will give us a material step forward to this end goal and we will be testing the solution as we end the year. We're continuing to remind ourselves the new to commercialize VorTeq by midyear 2021 or I'll stopping this. Our committed timeline has not changed. Next, we report on incubation. I discussed earlier our ZLD initiative, the first incubation efforts to graduate to an exciting business unit. In addition to the ZLD market, there are a multitude of potential applications for our ultra-high pressure PX in a variety of industries within and outside of water. We see significant future potential for our ultra-high pressures PX technology and believe it could become a significant percentage of our revenue in the coming years. We're also making progress on the second PX incubation initiatives targeted at a very large growth of industry currently undergoing regulatory driven transformation. While this product has the potential of being transformative in much the same manner, the PX transformed the desalination industry, we are at the technology feasibility stage and so we'll forego detail discussion at this time. We expect to report on the progress of incubation efforts when we speak to you again in March, at which time, we will have either prove out technically feasibility or seek investment. Finally, we mentioned last quarter that we are working on a project that will expand the aperture of our PX technology platform, thereby creating new PX applications in new industries. This project is a zero mixing PX. Zero mixing simply means that there is no commingling of fluids as columns of liquid transfer their pressures within the PX. Such mixing dose occur in our current applications in desalination and in oil and gas, but mixing however slight can exclude the PX from the applied in many applications such as gas processing or chemical among others where our technology could potentially help reduce energy consumption and thereby cost new existing systems. We have already proven the technical feasibility of this extension of our technology and we are now working on longer life and reliability. As we begin to apply this technology to new applications, we will update you on our progress and the potential of these new markets. With that, let's turn to ESG. As you know, we released our inaugural ESG report in September. While our business has always been aligned with sustainability issues such as addressing global water scarcity and improve access to affordable and clean energy. Our ESG report reflects our commitment to become more sustainable and resilient business. The initial guide to build our ESG program will base on our business growth as well as inputs from our key stakeholders. The pursuit of more efficient, sustainable customers' solutions has been the core of our DNA, since our founding more than 20 years ago. We're proud of the impact that our technology has been making desalination more efficient and sustainable particularly as our growth comes from growing water scarcity. Our new ventures will continue to focus our energy efficiency and endowment. As we use own pressure exchange technology to drive new growth opportunities, we desire to do so while providing new efficient and sustainable solutions to industrial needs. This is an exciting time at Energy Recovery. Our water team is focused on maintaining the momentum of our desalination business as well as expanding our reach with launch of the new ZLD product. Our Oil & Gas team is focused on finding finance and commercializing VorTeq. And finally, our incubation efforts are focused on achieving technical verification on one product that could prove transformative and another that could further expand the aperture of our PX phase platform. We're transitioning Energy Recovery into a growth company on the basis of our very versatile pressure exchanger. We are giving you insights to this transition by reporting our progress, our wins and our failures. We are investing our hard earned cash and you should know how and why we are investing it. We will continue to tell you what to expect, give you updates on our progress, and provide details on the outcomes. If we fail, you will know why. But when we succeed, you should not be surprised. In short, you will see every punch we land and every step we take, and we do not plan to take hand fist. With that, I hand other over to Joshua. -------------------------------------------------------------------------------- Joshua Ballard, Energy Recovery, Inc. - CFO [4] -------------------------------------------------------------------------------- Thank you, Bob. As you saw last quarter, each channel in the water business continues to experience different dynamics. Mega-projects remain dominant, growing 70% year-on-year in the quarter and an impressive 48% year-to-date. As expected both the OEM and aftermarket channels remain weak as compared to 2019, falling 22% and 40% respectively in the quarter from a year ago. Based on Bob's affirmation of at least 25% growth in our Water business this year, you should expect a very strong fourth quarter. I've mentioned in the past calls that it's hard to pinpoint quarterly trends in our business. In both 2018 and '19, we experienced the drop off in sales in the fourth quarter. However, this year, our fourth quarter sales should be comparable to that of the third quarter. As we looked at '21, and '22, we do expect to see our OEM and aftermarket channels recover; however, the extent of that recovery will largely depend on the global effects of COVID over this winter and next spring. While some industries will remain weak within these channels regardless, most notably travel and hospitality. At this time, we believe pent up demand and other industries may help return the OEM and aftermarket channels to more normalized levels, which is leaning toward increased confidence in projections for next year. I should also note that revenue from our new ZLD market is not yet included in these projections, as we build our pipeline and grow more comfortable, will provide more clarity. That being said, it's probably fair to assume that our initial revenue will be in the single digit millions the first couple of years, with considerably more growth in the future. Also note that these projects will be of a different nature than the larger Mega-project desalination plant driving our water growth today. A typical ZLD project will be in the range of $50,000 to $150,000 in revenue, with our potentially a much larger number of these projects than we've seen in desalination. For example, if we assume $100 billion market in China, as Bob outlined, this will imply roughly 100 projects, whereas in desalination it could be as low as 10. Our product gross margin decreased by 360 basis points as compared to Q3 2019 which showed a healthy 550 basis point increase from our low mark in the second quarter of this year and somewhat exceeded our expectations this quarter. Our margin strengthening over last quarter is largely due to our return to normal production levels at the end of Q2. While we did have a small effect from COVID due to delay in the commissioning of our new ceramics plant in Tracy, California, that effect was muted compared to prior quarters. We are pleased with how well our manufacturing team is operating within the restrictions of COVID and we continue to work under strict protocols to ensure the safety of our employees as well as the continuity of our business. In addition, our decreased OEM sales led to lower than expected sales of turbochargers and pumps, which proved accretive to margins as these products are less profitable than our PX sales in this channel. Last year, we mentioned some margin pressure owning the low ASPs as a result of bigger order sizes as we serve ever larger desalination process. We expect the trend to continue in Q4 and around the fiscal year with roughly 68% to 69% gross margin despite a reduced effect from COVID. As we look to 2021, the fundamentals of our gross margin will remain largely the same, excluding the potential of any temporary COVID-19 related effects. At this time, we don't expect to see a shift in our water business outside of this 68% to 70% range. Let's now turn to our operating expenditures where we have reported a decrease of 9% compared to Q3 2019. While our OpEx is somewhat lower than planned today due to COVID, the real story is an R&D where you will see a 23% decrease compared to Q3 last year and a similar decrease as compared to the first half of 2020. While our R&D expense may increase somewhat in Q4, we expected to remain roughly 15% to 20% lower than the first half of 2020. If there is a single thing at bottom I want you to hear, it is that of discipline, discipline in our R&D efforts as well as our operations and by extension, our expenses. For example, this year we terminated some projects altogether that were not achieved our commercial KPIs in expenses from these projects. And as we look at our OpEx going forward, while we expect OpEx to grow, you're focused on reducing our spend as a percentage of revenue over the next 2 to 3 years to a more normalized level as related to our peers in the market. Over the past decade, we have reported annual OpEx higher than 60% to 65% of revenue every year. It would have been in a similar range this year and after the second quarter termination of this Schlumberger contract and subsequent GAAP recognition of the remaining license and development revenue. We are targeting our OpEx to drop to a range of 35% to 40% of revenue by 2022, subsequently to reduce it to the low 30s, which will be more in line with our peers in the market. Sustaining of OpEx will be done in two ways. First, we will be capping our R&D as a percent of revenue in our baseline budget. Our R&D expenses averaged over 20% of revenue in the past few years due to our elevated spend on the VorTeq. In 2021, we'll be targeting a range closer to 15% to 20%, with the goal lowering it further in 2022 towards a 10% to 15% range. Keep in mind that this percentage will be decreasing despite the fact that we are guiding total revenues lower next year due to this year's increase in revenue from the termination of the Schlumberger contract. You can expect a clear reduction in R&D by the second half of next year, as we reduced spend on the VorTeq and wind down those R&D activities. In addition, based on R&D spend on our incubation projects is expected to remain in the single digit millions a far cry from the levels that we saw with the VorTeq. Second, we will continue to leverage our existing infrastructure, which will slow G&A growth in the coming years. We have invested significantly in the new systems past 18 months to better modernize our operations, to leverage our back office as we grow and we should see the fruits of this labor as we expect G&A spending growth to continue to lag that revenue. This year G&A spend is somewhat lower than plan due to COVID-19. Next year, we expect more normalized G&A spend and growth will generally occur from inflation and a reversion to the norm rather than increasing resources. I expect total G&A to grow more than 10% in 2021 and further decrease in growth on subsequent years as like R&D we aim to reduce G&A as a percent of revenue to the mid to high teens over the medium to long term. Sales and marketing spend is expected to stay roughly where it is today, around 10% to 12% of revenue. Lastly, as we concern OpEx, please keep in mind that our current levels spend is soon success with the VorTeq. If the VorTeq does not commercialize in 2021, our overall OpEx spend would decline considerably as we reduce activities in our Oil & Gas business unit and cease R&D. If modeling you keep similar levels of OpEx, you should then assume revenue from the commercialization of VorTeq. If we commercialized the VorTeq, we expect up to a 40% to 50% reduction in Oil & Gas OpEx spend overall, with about half of that reduction due to shifting spend in the cost of goods sold once we begin to generate revenue and the other half to decreased R&D. Also, this will result in an overall reduction in total R&D spend of at least 20% to 25% next year. Total reductions will depend on how quickly we commercialize or cease operations. Finally, a few words on our cash and investments position which ended at $160 million for the quarter. We continue to see no effect on cash from the global economic uncertainty. In fact, our accounts receivable is the cleanest it has ever been, which is reflective of the strong position the desalination industry finds itself in despite the strange times. For now we continue to shift our corporate bond portfolio into cash and securities mature. As the future becomes more certain, we'll revisit our longer term plans. CapEx investments look to finish the year in the middle lower end of the $8 million to $10 million I guided this time last year. Our baseline CapEx for 2021 is planned at $5 million to $7 million. Now this baseline excludes any CapEx related to potential commercialization of the VorTeq, which will become clear, if and when we commercialize and we'll provide more clarity at that time. With that, let's move to the question-and-answer portion of our call. Thank you. ================================================================================ Questions and Answers -------------------------------------------------------------------------------- Operator [1] -------------------------------------------------------------------------------- Thank you. At this time, we will be conducting a question-and-answer session. (Operator Instructions) Our first question is from Pavel Molchanov with Raymond James. -------------------------------------------------------------------------------- Pavel Molchanov, [2] -------------------------------------------------------------------------------- I want to just review the guidance targets that you gave, make sure we all heard them right. Following 25% water revenue growth this year, it should slow to 10% growth next year, but then reaccelerate to 25% in '22. Is that correct? -------------------------------------------------------------------------------- Bob Mao, [3] -------------------------------------------------------------------------------- Correct. Yes, that is correct. -------------------------------------------------------------------------------- Pavel Molchanov, [4] -------------------------------------------------------------------------------- So what gives you the confidence that '22 will -- that will see the acceleration in the growth rate? Is it specific projects, specific geographies, specific customers? -------------------------------------------------------------------------------- Bob Mao, [5] -------------------------------------------------------------------------------- Actually, all of the above specific projects, specific geographies, and in fact, we already have some backlog going into 2022. So, it's not depending on macro market trends only, it is underground actually project by project, customer by customer. -------------------------------------------------------------------------------- Pavel Molchanov, [6] -------------------------------------------------------------------------------- And does it include retrofits of legacy plants? Or is it or are you only looking at greenfield new builds? -------------------------------------------------------------------------------- Bob Mao, [7] -------------------------------------------------------------------------------- Both. -------------------------------------------------------------------------------- Pavel Molchanov, [8] -------------------------------------------------------------------------------- My final question was about your comment about an industry that is being transformed by government regulation. And I'm sorry, if this is a silly question, but are you referring to the Oil & Gas industry or something else? -------------------------------------------------------------------------------- Bob Mao, [9] -------------------------------------------------------------------------------- We will clarify that next call as we are in the technical feasibility phase. -------------------------------------------------------------------------------- Operator [10] -------------------------------------------------------------------------------- Our next question is from Ryan Pfingst with B. Riley Securities. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [11] -------------------------------------------------------------------------------- In terms of your inventory of VorTeq equipment for the new single cartridge skin design, if the opportunity presented itself, could you simultaneously execute one well with Liberty and another with a different pressure pumper? If not, are you prioritizing the first attempted well with Liberty above all other options? Or if another interested party wanted to conduct the live well test before Liberty customers ready, would you move forward with that opportunity? -------------------------------------------------------------------------------- Bob Mao, [12] -------------------------------------------------------------------------------- We have enough inventories to those. So that pleasant opportunity always. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [13] -------------------------------------------------------------------------------- Okay. That's helpful. And then for hurdle numbers three on the path to commercialization, the buying of frac sand that the cartridge can process before needs to be repaired or replaced. How far along are you now towards your target? I know that by year-end, you aim to be at 50% with clear visibility, on raising a hundred percent. Could you give some insight on maybe what percentage you're at now or where you exited the third quarter? -------------------------------------------------------------------------------- Bob Mao, [14] -------------------------------------------------------------------------------- We are on track to reach those targets. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [15] -------------------------------------------------------------------------------- Okay. So on track for 100% visibility by your end. -------------------------------------------------------------------------------- Bob Mao, [16] -------------------------------------------------------------------------------- Yes. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [17] -------------------------------------------------------------------------------- Great. And then turning to the new PX derivative product developments, could you give some other examples of potential end users that you're investigating now? -------------------------------------------------------------------------------- Bob Mao, [18] -------------------------------------------------------------------------------- We shared particularly with zero mixing and that will open up additional end user into chemicals industry where no mixing is allowed at all. -------------------------------------------------------------------------------- Ryan James Pfingst, B. Riley Securities, Inc., Research Division - Associate [19] -------------------------------------------------------------------------------- All right. Thank you. And then maybe just one last one for Josh, could you please provide the third quarter breakdown for Water revenue by segments? -------------------------------------------------------------------------------- Joshua Ballard, Energy Recovery, Inc. - CFO [20] -------------------------------------------------------------------------------- Sure. It's 76% for the Mega-Projects, 15% for OEM and about 10% for aftermarket. -------------------------------------------------------------------------------- Operator [21] -------------------------------------------------------------------------------- (Operator Instructions) Our next question is from Ken Hirschberg, Private Investor. -------------------------------------------------------------------------------- Unidentified Analyst, [22] -------------------------------------------------------------------------------- Congratulations on the excellent quarter and all the progress you're making. Could you please give us an update on the commercialization of the IsoGen and IsoBoost? Thank you. -------------------------------------------------------------------------------- Bob Mao, [23] -------------------------------------------------------------------------------- On that one, we are in discussion with potential customers to deploy our standard product. And of course, our first project is fully in operation and the very happily accepted by our customers. So, what we look for here is for a standard product applicable to a larger base of customers rather doing individual almost custom-made projects. So, we're making progress. We expect to report more at the next earning call. -------------------------------------------------------------------------------- Unidentified Analyst, [24] -------------------------------------------------------------------------------- Is it for IsoGen and IsoBoost? -------------------------------------------------------------------------------- Bob Mao, [25] -------------------------------------------------------------------------------- Yes, both IsoGen and IsoBoost. Did I answer your question? -------------------------------------------------------------------------------- Unidentified Analyst, [26] -------------------------------------------------------------------------------- Yes, you did. Thank you very much. I appreciate that. -------------------------------------------------------------------------------- Bob Mao, [27] -------------------------------------------------------------------------------- Thank you. -------------------------------------------------------------------------------- Operator [28] -------------------------------------------------------------------------------- Ladies and gentlemen, we have reached the end of the question-and-answer session. Now, I'd like to turn the call back to James Siccardi for closing remarks. -------------------------------------------------------------------------------- James Siccardi, Energy Recovery, Inc. - VP of IR [29] -------------------------------------------------------------------------------- I want to thank everyone for joining us today. For your convenience, we've decided for our prepared remarks up on our website, you can access when you chance to get in. Thank you very much for joining us and we look forward to speaking with you again in March. Please be safe. Thank you. -------------------------------------------------------------------------------- Operator [30] -------------------------------------------------------------------------------- This concludes today's conference. We thank you for your participation. You may disconnect your lines at this time. Goodbye.

Excerpt from:
Edited Transcript of ERII.OQ earnings conference call or presentation 29-Oct-20 9:00pm GMT - Yahoo Finance

Comprehensive Report on Withania Somnifera Extract Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and…

ReportHive added most up-to-date research on Withania Somnifera Extract Market Growth Factors, Applications, Regional Analysis, Key Players And Forecasts By 2026 to its huge collection of research reports.

Withania Somnifera Extract Market includes Overview, classification, industry value, price, cost and gross profit. It also covers types, enterprises and applications. To start with, analytical view to complete information of Withania Somnifera Extract market. It offers market view by regions with countries, development in Withania Somnifera Extract industry, opportunity with challenges, sales strategies, growth strategies and revenue analysis to include price. Withania Somnifera Extract Market report helps to analyses competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Withania Somnifera Extract Market Sales 2020 Industry Trend and Forecast 2026.

Withania Somnifera Extract Market Leading Players: Life Extension, Taos Herb Company, General Nutrition Centers, Jarrow Formulas, Huge Mountain, Organic India, The Vitamin Shoppe, NOW Foods, Solgar, Solgar, Piping Rock, Swanson

Request for Sample Report (Including COVID19 Impact Analysis, full TOC, Tables and Figures) of Withania Somnifera Extract Market

Withania Somnifera Extract Market impact Factors Analysis:Technology Progress/Risk, Substitutes Threat, Economic/Political Environmental modification. Technology Progress in connected trade, shopper Needs/Customer Preference modification.

The top geographical regions studied in this research report include North America, Europe, Asia-Pacific, Middle East, and Africa, South America and the rest of the world. The growing Withania Somnifera Extract Market and its progressive impact on the global economy is featured in this study. The competitive analysis of major Withania Somnifera Extract Industry players, market size analysis, dynamics, as well as the qualitative and numerical assessment, is conducted. The insights offered in this study will determine the potential of Withania Somnifera Extract Industry on global, regional and country-level paving the way for futuristic growth and investment feasibility.

The report covers exhaustive analysis on:

Market Segments Market Dynamics Market Size Supply & Demand Current Trends/Issues/Challenges Competition & Companies involved Technology Value Chain

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain in the Withania Somnifera Extract Market. The report Withania Somnifera Extract Market provide in-depth analysis of current market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on Withania Somnifera Extract Market segments and geographies.

This Withania Somnifera Extract Market report begins with a basic overview of the market. The analysis highlights the opportunity and Withania Somnifera Extract Market trends that are impacted the market. Players around various regions and analysis of each industry dimensions are covered under this report. The analysis also contains a crucial Withania Somnifera Extract Market insight regarding the things which are driving and affecting the earnings of the market. The Report offers SWOT examination and venture return investigation, and other aspects such as the principle locale, economic situations with benefit, generation, request, limit, supply, and market development rate and figure.

Market Segmentation: By TypeCapsule, Liquid

Market Segmentation: By ApplicationHealth Products, Drug

Quantifiable data:

Market Data Breakdown by Key Geography, Type & Application / End-User By type (past and forecast) Withania Somnifera Extract Market: Specific Applications Sales and Growth Rates (Historical & Forecast) Withania Somnifera Extract Market revenue and growth rate by the market (history and forecast) Withania Somnifera Extract Market size and growth rate, application and type (past and forecast)

>>> To get Incredible Discounts on this Premium Report, Click Here @

Highlights of TOC:

Report Overview: It includes major players of the global Withania Somnifera Extract Market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends: This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Withania Somnifera Extract Market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Withania Somnifera Extract Market are discussed.

Market Share by Manufacturers: Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type: This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application: Besides an overview of the global Withania Somnifera Extract Market by application, it gives a study on the consumption in the global Withania Somnifera Extract Market by application.

Production by Region: Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region: This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles: Almost all leading players of the global Withania Somnifera Extract Market are profiled in this section. The analysts have provided information about their recent developments in the global Withania Somnifera Extract Market, products, revenue, production, business, and company.

Market Forecast by Production: The production and production value forecasts included in this section are for the global Withania Somnifera Extract Market as well as for key regional markets.

Market Forecast by Consumption: The consumption and consumption value forecasts included in this section are for the global Withania Somnifera Extract Market as well as for key regional markets.

Value Chain and Sales Analysis: It deeply analyzes customers, distributors, sales channels, and value chain of the global Withania Somnifera Extract Market.

Key Findings: This section gives a quick look at important findings of the research study.

>>> Make an enquiry before buying this report @

Why Report Hive Research:

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc.

Contact Us:

Report Hive Research500, North Michigan Avenue,Suite 6014,Chicago, IL 60611,United StatesWebsite: https://www.reporthive.comEmail: [emailprotected]Phone: +1 312-604-7084

Life Extension, Taos Herb Company, General Nutrition Centers, Jarrow Formulas, Huge Mountain, Organic India, The Vitamin Shoppe, NOW Foods, Solgar, Solgar, Piping Rock, Swanson, Withania Somnifera Extract, Withania Somnifera Extract Industry, Withania Somnifera Extract Market, Withania Somnifera Extract Market 2020, Withania Somnifera Extract Market analysis, Withania Somnifera Extract Market Analysis in Developed Countries, Withania Somnifera Extract Market by Application, Withania Somnifera Extract Market by Type, Withania Somnifera Extract Market comprehensive analysis, Withania Somnifera Extract Market comprehensive report, Withania Somnifera Extract Market Development, Withania Somnifera Extract Market Evolving Opportunities With Top Industry Experts, Withania Somnifera Extract Market forecast, Withania Somnifera Extract Market Forecast to 2025, Withania Somnifera Extract Market Forecast to 2026, Withania Somnifera Extract Market Forecast to 2027, Withania Somnifera Extract Market Future Innovation, Withania Somnifera Extract Market Future Trends, Withania Somnifera Extract Market Google News, Withania Somnifera Extract Market Growing Demand and Growth Opportunity, Withania Somnifera Extract market growth, Withania Somnifera Extract Market in Asia, Withania Somnifera Extract Market in Australia, Withania Somnifera Extract Market in Canada, Withania Somnifera Extract Market in Europe, Withania Somnifera Extract Market in France, Withania Somnifera Extract Market in Germany, Withania Somnifera Extract Market in Israel, Withania Somnifera Extract Market in Japan, Withania Somnifera Extract Market in Key Countries, Withania Somnifera Extract Market in Korea, Withania Somnifera Extract Market in United Kingdom, Withania Somnifera Extract Market in United States, Withania Somnifera Extract Market insights, Withania Somnifera Extract Market is Booming, Withania Somnifera Extract Market is Emerging Industry in Developing Countries, Withania Somnifera Extract Market Latest Report, Withania Somnifera Extract Market opportunities, Withania Somnifera Extract market report, Withania Somnifera Extract market research, Withania Somnifera Extract Market Research report, Withania Somnifera Extract Market research study, Withania Somnifera Extract Market Rising Trends, Withania Somnifera Extract Market Size in United States, Withania Somnifera Extract market strategy, Withania Somnifera Extract Market SWOT Analysis, Withania Somnifera Extract Market Updates

Read more from the original source:
Comprehensive Report on Withania Somnifera Extract Market by global COVID-19 impact analysis, industry trends, business strategies, opportunities and...

The global Cold Plasma Market to go steady between 2018 and 2026 – The Think Curiouser

With the advancing electronics and semiconductors industry, the demand for cold plasma (CP) has been on the rise. While the demand for applications such as coating and finishing, surface treatment, adhesion, and etching, associated with printed circuit boards (PCBs) is soaring, the market for cold plasma is also expected to benefit from a slew of applications arising in other end use industries. Moreover, increasing applications in food safety will also push the market for cold plasma further, over the next few years. As depicted in a recent research report published by Persistence Market Research (PMR), the US$ 1.4 Bn global cold plasma market is presumed to observe stellar growth over an eight-year projection period. Between 2018 and 2026, the cold plasma market will possibly expand at a CAGR of 16.3%, as indicated by PMRs globalcold plasma marketreport.

The potential applications of cold plasma technology traverse a wide range, including the extension of product shelf-life and environmental sustainability. Such applications have been attracting the scientific community towards cold plasma research, over the years. The CP technique has already been proven to be an economic and environment-friendly technology in the textile industry. Textile companies are increasingly adopting cold plasma technique in an effort to deliver improved textile finishing.

Request For Report[emailprotected]

Cold Plasma Technology Soon to Transform Wound Treatment Space

While cold plasma applications in sterilization and disinfection are currently accounting for maximum revenue in the cold plasma market, rapidly emerging applications in wound healing and adhesion will reportedly create lucrative opportunities for stakeholders.

Coldplasmatech GmbH, a German company, is looking forward to introduce a novel CP technology that could potentially revolutionize the wound care treatment platform, especially in emergency rooms in hospitals. The CP technology involves a patch of cold plasma made of silicone (as a part of the wound dressing), which can be used in treatment of chronic wound infections with the help of UV radiations and ions. This technology is presumed to provide a high-tech, efficient alternative to antibiotics, considering its ability to accelerate the wound healing process. If the trials based on the application of the cold plasma technology in faster wound healing deliver convincing and viable results, industry experts predict that the CP technology could become a widespread method for treatment of chronic wounds and infection, in near future.

Cold Plasma Technology to Win Preference over Conventional Processing Technologies

Among all end use industries generating demand for cold plasma, electronics and semiconductors are foreseen to reign supreme. Whereas, rising demand for cold plasma is expected to uplift the prospects for cold plasma in food processing and packaging, and plastics and polymers industries.

Advanced cold plasma technology is being widely used in the in-package decontamination of fresh foods. Shelf-life extension will also remain a key objective of fresh food industry participants, using cold plasma as a unit technology. With successful trials of the regulation of contaminants mediated by cold plasma, the applications of cold plasma in agriculture sector are expected to surge in near future. Additionally, research shows that it is possible to degrade the chemical residues of pesticides to relatively lesser toxic and safer structures, by using cold plasma. It also offers an excellent alternative to conventional fertilizers and pesticides.

As far as the processed and packaged food industry is concerned, cold plasma has been proven to hold immense potential as a safe and eco-friendly alternative to traditionally used chemical processes. Moreover, it is considered as a novel non-thermal technology for processing of foods, especially fruits and vegetables, and poultry and meat prominently attributed to the non-thermal nature, versatile design, and economic pricing of cold plasma. Research findings also confirm that cold plasma treatment poses no or minimal impact on a products chemical, physical, sensory, and nutritional attributes. However, it still remains to be seen whether cold plasma processing will completely replace the traditionally used processing technologies, as the research outcome is still in the pipeline and demands more extensive research in order to reach its potential.

Request Report[emailprotected]

Company Profiles

For in-depth competitive analysis, buy[emailprotected]


Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.


Persistence Market Research

305 Broadway

7th Floor, New York City,

NY 10007, United States,

USA Canada Toll Free: 800-961-0353

Excerpt from:
The global Cold Plasma Market to go steady between 2018 and 2026 - The Think Curiouser

3 Ways Social Distancing Could Be Affecting You That You Dont RealizeAnd the Supplements to Deal With It – Well+Good

Have you noticed lately that your social skills are, well, not great? If you find yourself rambling non-stop whenever you have real, in-person interactions (finally!) oron the opposite side of the spectrumhaving no clue how to answer a basic how are you? it could be the result of all that alone time.

And while theyre super important, social distancing and self-isolation have taken a toll on more than just the ability to socialize. Licensed clinical psychologist Aimee Daramus, PsyD, says extreme hanger, sleepless nights, or unexplained pain and exhaustion are also signs that this new normal (well never say it again, we swear), is affecting your body.

According to Dr. Daramus, its normal to feel bad when something bad is happening around you. Feeling bad and not functioning at 100 percent are pretty reasonable right now, she addsso consider that professional permission to cut yourself a break.

The upside, though, is that you can help yourself feel less blah by integrating some supplementswith the purpose of supporting your specific ugh areainto your everyday.

Thats why after picking Dr. Daramuss brain about all the effects of self-isolation (keep on reading for those), we tapped Michael A. Smith, MD, director of education at Life Extension, to pinpoint the specific supplements that can help you out when those effects hit you extra hard.

In addition to being confined to your home (already a doozy), this year may have brought other hardships you didnt see coming, which can result in an overall feeling of uneasiness. People are experiencing multiple losses right nowfrom death to unemployment to milestones that they were looking forward to and traditions they didnt get to participate in, Dr. Daramus says.

While no supplement is the answer to anxiety or depression (and you should definitely talk to a doctor if thats a concern for you), Dr. Smith suggests Life Extension FLORASSIST Mood Improvewhich features specific strains of probiotics as the superstar ingredientsfor some overall emotional well-being support.

Probiotics are so much more than gut health, and its critical, he says. Your microbiome has connections throughout your body, and one of those is mood. As an example, your gut makes serotonin as much as your brain does. (And thats part of the brain-gut connection.)

Along with adding a probiotic to your daily mix, be sure to prioritize self care. Whether that means sticking to your workout routine, going for a long midday walk to clear your head, or even taking fifteen minutes to just unplug from your laptop and chilldedicate time to just being.

If youve noticed yourself feeling more irritable or ready to burst into tears every time you see a puppy, its probably not because Mercury is in retrograde (at least not just because of that).

Emotions are closer to the surface and we dont have all of our usual coping skills, so its easier to cry, lash out at someone, drink too much, eat too much, or overindulge in other ways, she says.

Since a lot of those problems can stem from stress, and unfortunately nothing (yet) exists that can just zap the stress out of your body, Dr. Smith recommends opting for Life Extension Enhanced Stress Relief on the days you wake up overly on-edge. It has L-Theanine (green tea) and lemon balm together, and these ingredients can produce a nice calming effect without knocking you out, he says. And who couldnt use some more calm?

All of these effects of self-isolation fold into one another, so if youre feeling stressed or sad, your sleep might be offand vice versa for when you dont get enough sleep.

To combat those restless nights when you cant shut your mind off, Dr. Smith says Life Extension Fast-Acting Liquid Melatonin is a good go-to.* Its perfect for that person who doesnt need it every night, but who has bad days every once in a while.

So, when you feel the hours of ceiling-staring coming, you can take a deep breath, shut off your devices, and rely on your sleepy time sidekick. Oh, and speaking of deep breathing, maybe the next time you meet up with a pal, take a deep breath and then start rambling.

Paid Content for Life Extension

Top photo: Kathrin Ziegler/Getty Images

*For occasional sleeplessness

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Original post:
3 Ways Social Distancing Could Be Affecting You That You Dont RealizeAnd the Supplements to Deal With It - Well+Good

Mortal politics – The River Reporter


(Applause.) Thank you. Thank you very much. Please yes, thank you please, be seated. (Applause continues.) Thank you again. (Applause subsides.)

My dear friends and fellow mortals:

It is my distinct pleasure, as well as honor, to address this fifth gathering of the Mortal Americans Party, and to accept your nomination to be your candidate for Prime Speaker of the New American Democratic Republic. (Applause.)

In the Mortal Americans Party, we have, at last, I believe, found the one thing that ultimately unites us all. Our friends in the Transhumanist Life Extension Party and the Eternal Life Party may disagree, of course, and we look forward to our ongoing discussionsbut for now, we have come together here today on one basic fact:

Were all gonna die. (Applause.)

Liberals, conservatives, atheists and believers alikeall races, genders, variations, mutations and modificationswhatever our backgrounds, whatever our present circumstances, whatever our dreams for the future, we have learned that we must always keep that one inalterable fact somewhere in our minds and let it inform all that we do.

For too long, we tried to pretend that death didnt matter. We kept it in the closet. We tried to hold it at bay with vitamin supplements and dentures, Viagra and facelifts. We idolized youth and kept the elderly at a safe distance.

But the pandemics, and the years of upheaval they have caused, have changed all that.

There is no one way to cope with mortality, of course. Some of us are of the eat, drink and be merry philosophy. (Drunken cheers from the Hedonist Caucus.) Some of us take refuge in the comforts of spirituality. (Shouts of Amen! and Namaste!) Some of us embrace the dark aspects of fatalism. (Silence from the goths under the bleachers.) We respect and honor each others decisions, as we would have our own respected and honored. But I think we who have come here, at least, have agreed that it is important to do what we can, in the time that we have, where we are, with what we have been given. (Applause.)

We have learned that it is not just about us, but about those who preceded us in history, and those to come, who will take up our path in the future. We have learned both to take the long view and to live with gratitude in the moment. We have learned that short-term personal gain is unfulfilling when compared to helping our fellow mortals cope with the pains and challenges of life. We have learned that we cannot be uninvolved in the lives of others, however hard we might try. We have learned that while it is good to live independently and self-sufficiently as possible, there is no shame in asking for help. We have learned, painfully, that unbridled self-centeredness, the idea that I gotta get mine, and to hell with the rest of you, does not workneither for an individual nor a nation.

Most of all, we have learned that todaythis momentis ineffably precious. We must use it as best we canwhether it is to go vote, to help a neighbor, to take care of ourselvesbecause we do not know if we will be given another chance.

So let us move forward, my friends, towards the inevitable, with uplifted spirits. Give out of your heart, as our slogan goes, until your heart gives out.

Let me leave you with the words of Phil Ochs:

And I wont be laughing at the lies, when Im gone

And I cant question how, or when, or why, when Im gone

Cant live proud enough to die, when Im gone

So I guess Ill have to do it while Im here.


Here is the original post:
Mortal politics - The River Reporter

Oral & Dental Probiotics Market (Impact Of Covid-19) Opportunities, Top Vendors, Industrial Analysis, Business Investment And Trends In Industry…

Chicago, United States: Global Oral & Dental Probiotics Market Report 2021, Forecast to 2026, The report focuses on encompassing several factors such as global distribution, manufacturers, and various regions. The report has summed up industry analysis size, share, application, and statistics associated with the global Peptide Synthesis market. The report delivers an in-depth competitive landscape, Growth opportunities, market share coupled with product type and applications. The report also estimates comprehensive market revenue along with Growth patterns, and the overall volume of the market.

Crucial information and forecast statistics covered in the Oral & Dental Probiotics Market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

Key players covered in the report include:Now Foods, Hyperbiotics, Oragenics, Life Extension, Lallemand

>Request for Sample Report (Including COVID19 Impact Analysis, full TOC, Tables and Figures) of Oral & Dental Probiotics Market @

NOTE: Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Oral & Dental Probiotics Market which would mention How the Covid-19 is affecting the Oral & Dental Probiotics Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Oral & Dental Probiotics Players to Combat Covid-19 Impact.

Valuable information covered in the Oral & Dental Probiotics Market report has been segregated into key segments and sub-segments.

By Service typePowderChewable tabletsOthersBy End useChildAdultApplication 3

Oral & Dental Probiotics Market: Competition Analysis

The Report Hive Research study presents a comprehensive analysis of global, regional, and country-level players active in the Oral & Dental Probiotics Market. Competitive information detailed in the Oral & Dental Probiotics Market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player.

Important Questions Answered in the Oral & Dental Probiotics Market Report

Key Offerings of the Report

>>>>Get Full Customize Report @

As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.

Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the epicenter of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.Compared with the United States, Europes economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germanys GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.Thanks to the effective control and policy support of the new epidemic, Chinas economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Oral & Dental Probiotics market in this environment.

In terms of revenue, this research report indicated that the global Oral & Dental Probiotics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Oral & Dental Probiotics industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.

The ????Now Foods aims at producing XX Oral & Dental Probiotics in 2020, with XX % production to take place in global market, ????Hyperbiotics accounts for a volume share of XX %.

Why Go For Report Hive Research?

Report Hive Research delivers strategic market research reports, statistical surveys, industry analysis and forecast data on products and services, markets and companies. Our clientele ranges mix of global business leaders, government organizations, SMEs, individuals and Start-ups, top management consulting firms, universities, etc. Our library of 700,000 + reports targets high Growth emerging markets in the USA, Europe Middle East, Africa, Asia Pacific covering industries like IT, Telecom, Semiconductor, Chemical, Healthcare, Pharmaceutical, Energy and Power, Manufacturing, Automotive and Transportation, Food and Beverages, etc. This large collection of insightful reports assists clients to stay ahead of time and competition. We help in business decision-making on aspects such as market entry strategies, market sizing, market share analysis, sales and revenue, technology trends, competitive analysis, product portfolio, and application analysis, etc.

Get in Touch with Us :

Report Hive Research

500, North Michigan Avenue,

Suite 6014,

Chicago, IL 60611,

United States

Website: :

Email: [emailprotected]

Read the original post:
Oral & Dental Probiotics Market (Impact Of Covid-19) Opportunities, Top Vendors, Industrial Analysis, Business Investment And Trends In Industry...

Reishi Mushroom Extract Market Global Trends, Share, Size, Growth, Opportunities, and Forecast, Covid-19 Impact by 2026 – The Think Curiouser

An innovative research study has been offered by Futuristic Reports, offering a comprehensive analysis of the Global Reishi Mushroom Extract Market where users can get an advantage from the comprehensive market research report with all the essential useful information. This is the newest report, covering the existing COVID-19 impact on the Reishi Mushroom Extract market. It has fetched along with numerous changes in market conditions. This segment also provides the Reishi Mushroom Extract scope of different applications and types that can potentially influence the future market. The comprehensive statistics are based on current trends and historical milestones.

This report also delivers an analysis of production volume about the global Reishi Mushroom Extract market and each type from 2020 to 2026. The Reishi Mushroom Extract report explicitly features the market share, company profiles, regional viewpoint, product portfolio, recent developments, newest strategic analysis, key players in the market, deals, circulation chain, manufacturing, production, and newest market entrants. The existing Reishi Mushroom Extract market players, brand value, popular products, demand and supply, and other significant factors identified with the market help players will better understand the market scenario.

Get Exclusive Sample Copy on Reishi Mushroom Extract Market at:

Impact of COVID-19 on Reishi Mushroom Extract Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Reishi Mushroom Extract Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international market. The epidemic has immediately interrupted the requirement and supply series. The Reishi Mushroom Extract report also assesses the economic effect on firms and economic demands. Futuristic Reports has accumulated advice from several delegates of this Reishi Mushroom Extract business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

Some of the key players operating in this market include:

( Vitacost, Swanson, Life Extension, Natures Answer, Natures Way, New Chapter, Solaray, Solgar, Source Naturals, Vital Nutrients, Bio-Botanica)

Based on Product Type, Reishi Mushroom Extract market report displays the production, profits, cost, and market segment and growth rate of each type, covers:

Powder Liquid

Based on end users/applications, the Reishi Mushroom Extract market report focuses on the status and viewpoint for major applications/end users, sales volume, market share, and growth rate for each application. This can be divided into:

Health Care Products Essential Oil Others

Grab Your Report at an Impressive Discount! Please click here:

The report offers a comprehensive assessment of the progression and other Reishi Mushroom Extract market features in significant regions, including South Korea, Taiwan, North America, Europe, Canada, Germany, France, Southeast Asia, Mexico, and Brazil, Pacific, and Latin America. U.S., U.K., Italy, Russia, China, Japan, etc.

Features the following key factors:

Some of the Key Questions Answered in this Report:

Inquire More About This Report @

Our Other Reports:

Global Sewer Cameras Market Research Report

Global Manganese Powder Market Research Report

Global Nutritional Yeast Market Research Report

Global Mountaineering Packs Market Research Report

Futuristic Reports

Name: Mark RiveraTel: +1-408-520-9037Email: [emailprotected]

Read this article:
Reishi Mushroom Extract Market Global Trends, Share, Size, Growth, Opportunities, and Forecast, Covid-19 Impact by 2026 - The Think Curiouser

Will America Help Britain Build a New Nuclear Warhead? – War on the Rocks

The future of the United Kingdoms nuclear deterrent depends, in part, on decisions being made right now in the U.S. Congress. At stake are Britains plans to build a replacement for its current nuclear warhead. According to the U.K. defense secretary and senior U.S. officials, the United Kingdoms program is reliant on the United States pursuing its own new warhead program of record, the W93. But the Donald Trump administrations Fiscal Year 2021 request for funds for the W93 was first nixed by House appropriators and then excluded from the stopgap continuing resolution. It is neither clear whether the W93 program will eventually make it into the budget proper, nor whether it would be taken up immediately by a potential incoming Joe Biden administration.

The United Kingdoms new warhead will be housed in the U.S. Navys proposed new Mk7 aeroshell, and is intended to be developed in parallel with the W93 warhead, sharing key design parameters and using some common non-nuclear components. In April, U.K. Defence Secretary Ben Wallace wrote to members of Congress on relevant committees, claiming that their support to the W93 program in this budget cycle is critical to the success of our replacement warhead program and to the long-term viability of the U.K.s nuclear deterrent. Senior Trump administration officials have also repeatedly told Congress that a failure to fund the W93 will prevent the United States from supporting the British program. The future of a nuclear deterrent that the United Kingdomcallsits ultimate insurance policy as a nation and a contribution to the ultimate guarantee of collective Euro-Atlantic security is being called into question.

Most media discussion of Wallaces letter focused on the propriety of the defense secretary lobbying Congress. But Wallaces letter was remarkable on grounds of substance, not just process. At face value, his letter made very serious claims, suggesting that the fate of the United Kingdom as a nuclear power is in the hands not of members of Parliament, but of congressional appropriators. These claims deserve close interrogation not least by Parliament, which has so far failed in its duty of scrutiny. British legislators should be asking why, exactly, a new warhead is needed; what the backup plan in case U.S. assistance is disrupted; what military and technical requirements are being set for the new warhead; whether the United Kingdoms fraying infrastructure can deliver what is asked of it; and how much this endeavor will cost. Buried in these questions are significant risks and long-term strategic choices for the United Kingdom, the future of its nuclear deterrent, and Anglo-American defense ties.

Dependent Deterrent

The United Kingdoms nuclear force is strongly dependent, in material and programmatic terms, on the United States. The Royal Navy deploys four nuclear-armed submarines equipped with the U.S.-built and maintained Trident II D-5 submarine-launched ballistic missile, drawing from a common missile pool at Kings Bay, Georgia. The essence of this cooperative relationship on delivery systems has been in place since the conclusion of the Polaris Sales Agreement in 1963, signed after Prime Minister Harold Macmillan persuaded President John F. Kennedy to sell the United Kingdom the Polaris submarine-launched ballistic missile. Bilateral cooperation on warhead-relevant matters, including the transfer to the United Kingdom of special nuclear material and non-nuclear weapon components, is authorized under the 1958 U.K.-U.S. Mutual Defense Agreement, which freed London from Washingtons postwar prohibition on nuclear cooperation under the 1946 McMahon Act.

The United Kingdom is currently working on a successor submarine, the Dreadnought class, which will replace the currently deployed Vanguard class in the 2030s, and which will share a common missile compartment with Americas own successor class, the Columbia. In 2006, Prime Minister Tony Blair secured from President George W. Bush an agreement that the United Kingdom would participate in a missile life extension program so that the Dreadnought class could continue to carry the Trident II D-5. In addition, London would be invited to participate in any program to replace or further life extend the D-5. A program is now underway to develop a successor missile once the D-5 leaves service in 2042, currently designated the D-5 Life Extension 2.

The basic parameters of the British warhead are thus set by the need for it to be certified for use with an American missile system and housed in an American aeroshell. The United Kingdoms current nuclear warhead, the Holbrook, is sometimes referred to as an Anglicized version of the U.S. W76. It is certainly a similar design, and is referred to as such by U.S. national laboratories, although the degree of similarity is not publicly known. Several non-nuclear components of the warhead are known to be procured from the United States, including the arming, fusing, and firing system; neutron initiator; and the gas transfer system. The United Kingdom has made some updates to the Holbrook while the United States has conducted a life extension of the W76, now designated the W76-1, including at least the incorporation of the Mk4a arming, fusing, and firing system. However, it has not been publicly disclosed whether the United Kingdom has conducted an equally extensive life extension program of its own.

There is little reason to believe that the United Kingdom wishes to depart significantly from this model when it comes to building the next warhead. The structural incentives to hew closely to U.S. plans are strong. Procurement of non-nuclear components from the United States is seen as an obvious cost-saving measure, and reliance on U.S. facilities and information-sharing gives Britain a hedge against technological risks in design and certification. An explicit goal of the United Kingdoms program to modernize its nuclear infrastructure has in recent years been to increase engagement with the United States to align capabilities and requirements for any future warhead decision.

Unless the United Kingdom wants to diverge significantly from the United States, then its new warhead program needs a parallel U.S. program against which to align. Enter the W93. The announcement of a new program of record was good news for the U.K. nuclear establishment, which had been in a holding pattern during several years of U.S. deliberations and interservice wrangling. But the United Kingdom fields only one warhead in its nuclear arsenal, and so has considerably less margin for error than the United States, which already has two warhead types delivered by submarine-launched ballistic missiles (the W76-1 and W88, plus a lower-yield W76-2 variant), as well as the redundancy of two alternative delivery vehicles (land-based intercontinental ballistic missiles and strategic bombers), each with their own warhead types. The United Kingdom also appears to be working toward a rather pressing deadline. According to official U.K. statements, a replacement warhead could be needed as early as the late 2030s, and it has previously been estimated to take 17 years from a procurement decision to the eventual production of the warhead.

This sense of urgency leaves Britain in an uncomfortable position, because many in Congress do not appear convinced that the United States truly needs the W93 program to start right away. Funding for the W93 program was not anticipated to be required for two more years, and the timing of the administrations request has provoked pushback from Democratic legislators. One possible theory is that Trump administration officials want the W93 on the books before a potential Biden administration enters office. Another more concrete explanation is that U.S. defense officials might not trust the National Nuclear Security Administration the semi-autonomous agency within the Department of Energy which manufactures the United States nuclear warheads to deliver the W93 on schedule, and would like a more generous margin of error. The National Nuclear Security Administration request is only for the first of seven phases of warhead development, and calls for the relatively modest sum of $53 million, alongside a Pentagon request for $32 million for the Navy Mk7 program. The latter request, unlike that of the National Nuclear Security Administration, was originally approved by House appropriators.

Even if a potential incoming Biden administration agreed with the requirement for a new warhead for its submarine-launched ballistic missiles, it might still choose to delay the program. This could be a symbolic gesture toward reducing emphasis on nuclear weapons, or a practical recognition both that National Nuclear Security Administration already has four life extension or modification programs to execute and a new sea-launched cruise missile warhead to produce, and that the U.S. nuclear modernization program is shaping up to be spectacularly expensive at a time of COVID-19 induced budget pressure. Even without a conscious decision to delay the program, it might still be pushed back if a Biden administration wished to consider the W93 in the context of a Nuclear Posture Review, which would take time to complete.

Unanswered Questions

The United Kingdom, in other words, is in quite a bind. The defense secretary has stated, in writing, that the viability of the British deterrent depends on a program which the U.S. Congress might be about to stymie. It could be the case that, if work on the Mk7 aeroshell can start even in the absence of National Nuclear Security Administration funding for the W93, the United Kingdom could begin work on its own program. But the longer that Britain proceeds without a parallel U.S. warhead program in place, the greater the risks it would be incurring. Vanishingly little is publicly known about the decision-making process which has led to this point, which makes the precise degree of risk facing the United Kingdom very difficult to judge.

Congress has now had four public hearings at which the W93 was discussed, including several references to the programs importance to the United Kingdom, and the administration has given briefings on the rationale behind the program. Yet in the United Kingdom, where the stakes are allegedly much higher, the sum total of the governments public output on the warhead is a vaguely written statement to Parliament, and confirmation that the warhead will use the Mk7 aeroshell. This leaves open several key questions.

Why Has the United Kingdom Decided to Build a New Warhead, Rather Than Seeking to Further Refurbish or to Remanufacture Holbrook?

The fact that the United Kingdom has decided to build a new warhead at all, rather than seeking to further prolong the life of the Holbrook, is something that needs justifying. Has the United Kingdom made an independent judgment that a replacement warhead is essential, or is this decision simply the combination of a U.S. decision to proceed with W93 and the United Kingdoms preference for alignment? Ever since the 2006 White Paper in which the decision to renew the ballistic missile submarine force was taken, the U.K. government has repeatedly told Parliament that at some point a decision on whether to build a new warhead would be need to be made. That decision has now been made, and Parliament and the public do not know why.

It is not clear that the United States sees a critical need to replace the W76-1, which has recently been life-extended, providing for additional decades of use. Some discussions of the W93s role suggest that it could exist in parallel with both the W76-1 and the W88 as one of Americas three submarine-launched ballistic missile warheads. Were the United States to decide that the W76-1 could be further life-extended, or remanufactured from scratch, the U.K. government has not yet provided any public reasoning why the same could not be done for the Holbrook. Such reasons can certainly be imagined: there might be materials used in the original U.K. design that have now aged, and cannot for technical, legal, or safety reasons be remanufactured other than at disproportionate cost. There is also a case to be made that further life-extending old warheads introduces a degree of risk of technical failure that is unacceptably high for a country that depends on a single design, and that changes in the security environment, such as developments in missile defenses, could set future military requirements that the current warhead cannot meet. These arguments, however, have not yet been publicly made by the U.K. government.

What Are the Critical U.S. Activities on Which the U.K. Replacement Warhead Will Depend in the Next Few Years, and What Is the United Kingdoms Backup Plan if These Activities Are Not Funded?

The U.K. government has emphasized the need for its warhead to be compatible with Americas Trident system. What this probably means in practice is that the United Kingdom needs to know key parameters of the Mk7 aeroshell which will define the size, shape, mass distribution, and other aspects of the British warhead which will fit inside it. Beyond that, in order for the United Kingdom to be able to cooperate closely with the United States on key scientific and engineering aspects of the warheads design, manufacturing, and certification, the United Kingdom will need to know U.S. intentions for various design choices. Until the United States starts work on the W93 program, the United Kingdom will either have to delay its own choices or make assumptions about likely U.S. decisions in order to begin necessary work. Either path could involve increased costs and technical risk.

Beyond a small delay, more serious disruption to the W93 program raises very challenging questions: would the United Kingdom pursue indigenous production of components that would otherwise have been procured from the United States, and if so, at what risk and cost? If the United Kingdom still wishes to remain aligned with the United States, are there alternatives to a replacement warhead based on the W93/Mk7? More broadly, Parliament might ask whether such close alignment to the United States is truly worth the accompanying loss of sovereignty. It is often assumed that the United Kingdom has simply no other option, and a more independent program would certainly involve taking a greater share of technical risk and would very likely incur greater financial costs. Nevertheless, close alignment with the United States has downsides as well as upsides, including greater vulnerability to disruption or delayed supply of materials, components, and expertise, and less discretion in setting military and other requirements for the warhead. This is a strategically important choice which has not yet been fully debated in public.

What Are the Likely Requirements for the W93, and How Do These Relate to the U.K. Program?

Assuming that the W93 program does go ahead, the first phases of its development will involve, among other things, the drafting of military characteristics and a stockpile-to-target sequence. Taken together, these will define the performance requirements and physical characteristics of the weapon, as well as the environments and threats it will be exposed to that must be taken into account in its design. This will require deciding, for example, what explosive yield the warhead will have, what defenses it must defeat including nuclear, hit-to-kill, and (potentially) directed energy weapons and what kind of hardening and countermeasures will be necessary. Choices will also be made regarding surety requirements, such as whether to use insensitive high explosives, which could mean a relative increase in mass and volume.

Requirements set in the United States during this process are likely to determine or strongly influence several characteristics of the British warhead. Embedded in those requirements are important implications for U.K. policy and strategy, and although London is likely to have a voice in U.S. discussions over such questions, it will not have a deciding vote. Briefings by U.S. officials suggest, for example, that the W93 is intended to be of higher yield than the W76-1. If the United Kingdom were to follow this path, the overall explosive yield of its operational stockpile could increase for the first time since it began deploying Trident in 1994. The emphasis placed by U.S. officials on the W93s flexibility implies variable yield, which would be somewhat consistent with the existing lower-yield warhead variant the U.K. reportedly deploys at present, but would leave the United Kingdom vulnerable to accusations that it was reinforcing a global trend toward the development of supposedly more usable nuclear options. Any potential improvement to the warheads ability to strike hard targets might also draw criticism from those opposed to enhancements in nuclear weapon capabilities, as was the case when the U.K. began introducing the Mk4a arming, fusing and firing system. Lastly, U.K. defense planners might be thinking about future deterrence requirements for countries other than Russia, the traditional driver of U.K. warhead needs. This might have an impact on the requirements for a new warhead, such as on the question of the new warheads weight, which helps determine the maximum range that missiles can reach. This is a potentially relevant factor when considering the risk that future developments in anti-submarine warfare might complicate U.K. operations.

Can the United Kingdom Successfully Execute a Warhead Replacement Program?

The state of the United Kingdoms nuclear weapons infrastructure suggests that the country will face significant challenges in producing its next warhead, even if cooperation with the United States runs entirely smoothly. By now, at least three key U.K. facilities should have been up and running: Pegasus (to handle enriched uranium components), Mensa (to assemble and disassemble warheads), and Hydrus (to conduct hydrodynamic tests). None is fully operational. Pegasus has been suspended after initial designs were judged too expensive and unwieldy, Mensa is now being built at least six years late and at more than twice the original cost, and Hydrus has been replaced by a joint U.K.-French hydrodynamic facility in France not scheduled to be fully operational for the United Kingdom at least until 2022.

More fundamentally, this will be the first warhead the United Kingdom has designed for some thirty years, and the first ever without explosive nuclear testing. It will also be designed just as the last generation of Atomic Weapons Establishment employees with firsthand experience designing new warheads are retiring. With civil nuclear projects also planned for the coming decades, the Atomic Weapons Establishment will be facing considerable workforce recruitment, training, and retention challenges.

How Much Will the United Kingdoms New Warhead Cost?

In the context of the COVID-19 crisis, the forecast hit to the U.K. economy caused by Brexit, and an ongoing strategic review, there is likely to be financial pressure on the warhead program even if it is shielded from immediate cuts. Yet the government is staying remarkably coy about the projected costs of the new warhead. The 2006 White Paper estimated the cost to be 2 to 3 billion pounds ($2.6 to $3.9 billion). This estimate was confirmed in government documents as late as 2013. Since then, however, no official estimate has been provided, although the 2013 Trident Alternatives Review, a government-published document though not a statement of policy estimated the cost of a new submarine-launched ballistic missile warhead to be 4 billion pounds in 2012 prices.

The Nuclear Warhead Capability Sustainment Program, under which much of the supporting infrastructure for building a new warhead was supposed to be built, has an overall budget of 21 billion pounds spread out from 2005 to 2025, and is subject to the scrutiny requirements applied to major projects. The government has said that the program to build the new warhead will also be subject to those requirements, but is not giving a specific cost estimate, citing national security concerns. Likewise, it has not said which parts of the Nuclear Warhead Capability Sustainment Program will be subsumed under the new warhead program. It is certainly tricky to separate the costs of the new warhead from the overall costs of having nuclear infrastructure capable of maintaining the existing warhead. And yet not only has the U.K. government done so in the past making it difficult to imagine national security grounds for withholding the information now the U.S. government has also provided estimates of how much the W93 might cost: $14.4 billion, according to the Nuclear Security Administrations last published assessment.

Take Back Control

The United Kingdoms replacement nuclear warhead program is a long-term, complex, and expensive endeavor. It deserves proper scrutiny. And while many of the technical details of the U.K. warhead must remain classified, the broad parameters of the decision the government has made and the risks the program faces are fair game for public debate. The British public learned of the decision to replace the Holbrook warhead not because the government decided to announce it, but because U.S. officials told Congress and reporters in February. In several respects, the transparency of the U.S. government, and the persistence of Congress in extracting answers, is throwing the opacity of the United Kingdoms nuclear warhead program into stark relief. It is time for Parliament to take back control.

Matthew Harries (@harries_matthew) is a senior research fellow at the Royal United Services Institute for Defence and Security Studies (RUSI). He previously worked on the staff of the U.K. House of Commons Foreign Affairs Committee. Prior to that, he was managing editor of Survival and a senior fellow at the International Institute for Strategic Studies (IISS). This article is drawn from a research project supported by the John D. and Catherine T. MacArthur Foundation.

Image: U.S. Navy (Photo by John Kowalski)

See the rest here:
Will America Help Britain Build a New Nuclear Warhead? - War on the Rocks

Wellness Supplements Market : Incredible Possibilities, Growth With Industry Study, Detailed Analysis 2020-2027 | Leading Players Life Extension,…

A comprehensive analysis of the market structure along with the forecast of the various segments & sub-segments of the market have been delivered through this Wellness Supplements Market document. The market is greatly transforming because of the moves of the key players and brands including developments, product launches, joint ventures, mergers and acquisitions that in turn changes the view of the global face of ABC industry. This market research report is a window to the industry which explains what market definition, classifications, applications, engagements and market trends are. The Wellness Supplements Market business report defines CAGR value fluctuation during the forecast period of 2020-2026 for the market.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @

This Wellness Supplements Market analysis report offers all-inclusive study about production capacity, consumption, import and export for all the major regions across the world. Furthermore, the statistical and numerical data such as facts and figures are represented very neatly in this report by using charts, tables or graphs. This market document also involves strategic profiling of the major players in the market, comprehensive analysis of their basic competencies, and thereby keeping competitive landscape of the market in front of the client. The global Wellness Supplements Market report covers all the market shares and approaches of the major competitors or the key players in the market.

Market Analysis and Insights: Global Wellness Supplements Market

Wellness supplements market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 386.29 billion by 2027 growing at a CAGR of 6.45% in the above-mentioned forecast period. The growing awareness towards healthy lifestyles among the people globally will help in driving the growth of the wellness supplements market.

The major players covered in thewellness supplements marketreport areLife Extension, OPTAVIA LLC, Beachbody LLC, Natures Sunshine Products, Inc, Organo Gold., Thrive Life, LLC, Phytoscience Trvo, Oriflame Cosmetics AG, Melaleuca Inc, Shaklee Corporation, Arbonne International, LLC., Forever, L.L.C, Juice Plus+, Herbalife International of America, Inc, and Isagenix Worldwide LLC, Nikken Inc., Wellness Resources, Inc., The Daily Wellness Company, Otsuka Holdings Co. Ltd, Glanbia plc, Nestle, Nuskin, USANA Health Sciences, Inc., among other domestic and global players.Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Get Full TOC, Tables and Figures of Market Report @

Increasing ageing population, raising disposable income in developing countries and rising demands towards the healthy and cosmetic products will likely to accelerate the growth of the wellness supplements market in the forecast period of 2020-2027. On the other hand, gradual shift towards newer technologies and natural products and growth potential offered by emerging markets will further boost various opportunities that will lead to the growth of the wellness supplements market in the above mentioned forecast period.

Lack of traditional food categories, high cost of supplement food products, regulatory issues and increasing incidence of health issues will likely to hamper the growth of the wellness supplements market in the above mentioned forecast period.

This wellness supplements market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on wellness supplements market contact Data Bridge Market Research for anAnalyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Wellness Supplements Market Scope and Market Size

Wellness supplements market is segmented on the basis of dietary supplements, functional food and beverage, nutricosmetics and free from food. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Wellness Supplements Market Country Level Analysis

Wellness supplements market is analysed and market size insights and trends are provided by country, dietary supplements, functional food and beverage, nutricosmetics and free from food as referenced above.

The countries covered in the wellness supplements market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the wellness supplements market due to growing cognizance and acceptance of wellness products and increasing focus towards healthy lifestyles while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to rising aging population and growing disposable income of the region.

The country section of the wellness supplements market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Wellness supplements market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipments, installed base of different kind of products for wellness supplements market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the wellness supplements market. The data is available for historic period 2010 to 2018.

Customization Available: Global Wellness Supplements Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @

About Data Bridge Market Research :

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Here is the original post:
Wellness Supplements Market : Incredible Possibilities, Growth With Industry Study, Detailed Analysis 2020-2027 | Leading Players Life Extension,...

Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against…

Newswise SAN ANTONIO, TEXAS (October 19, 2020) Texas Biomedical Research Institute (Texas Biomed) Professor Luis Martinez-Sobrido, Ph.D., recently released study findings, alongside colleagues at the University of Alabama at Birmingham and Aridis Pharmaceuticals, Inc. indicating that a human monoclonal antibody (hmAb) 1212C2 showed promise for further clinical development for preventative use or as a therapy for SARS-CoV-2, the virus that causes COVID-19. Earlier this year, the consortium of scientists isolated specific B cells from patients infected with SARS-CoV-2 and developed a panel of hmAbs that not only bind to SARS-CoV-2 infected cells, but also neutralize the ability of the virus to infect cells. The hmAb 1212C2 was subsequently licensed to Aridis Pharmaceuticals.

Taking the study a step further, the scientists have shown, as outlined in the study on BioRxiv, that delivering hmAb 1212C2 directly to the lung through inhalation using Aridis proprietary formulation and plasma half-life extension, or by injection showed significant reduction in viral load in the lungs.

Antibodies are proteins produced by the bodys immune system to fight off infections. Monoclonal antibodies are commercially or experimentally produced antibodies derived from the original antibody producing cell. Scientists worldwide have shown that the Receptor Binding Domain (RBD) region of SARS-CoV-2s Spike protein is a key target for any drug that aims to stop the virus from attaching to cells through the human angiotensin converting enzyme 2 (ACE2) protein. If the virus cant attach to the cell, it cant infect and propagate. The hmAbs were discovered by the labs of Dr. James Kobie and Dr. Mark Walter at the University of Alabama at Birmingham in collaboration with Dr. Martinez-Sobrido.

In both lab and animal experiments, hmAb 1212C2 produced a preventative and therapeutic effect against SARS-CoV-2. In hamster models, delivering formulated and plasma half-life extended hmAb 1212C2 through a nebulizer at low dosage produced a significant reduction of the virus and lessened disease progression in the lungs.

These are critical findings as we look to develop vaccines and therapies that are not only effective, but also efficiently manufactured and easily administered to patients, Dr. Martinez-Sobrido explained.

Nearly 40 million people globally have contracted COVID-19 with more than one million deaths, and the worldwide pandemic is not slowing down. Neutralizing antibodies developed either by natural infection or through vaccination, or administered as a therapeutic are critical to the overall protection of the human population.

Administering targeted human antibodies that bind tightly to SARS-CoV-2 is a promising approach to advance therapies. We must have more effective therapies to reduce the death rate from this ongoing pandemic. I am excited about the opportunity to advance hmAb 1212C2 with Aridis Pharmaceuticals, said Dr. Larry S. Schlesinger, President/CEO of Texas Biomed.

The cohort of scientists licensed hmAb 1212C2 to Aridis for further development as both a possible prophylactic for preventing COVID-19 and as a treatment for COVID-19, while also looking at opportunities to use this hmAb in combination with other hmAbs, or with other antiviral therapies.

Staff in Dr. Luis Martinez-Sobridos lab who contributed to this research include Jun-Gyu Park, Fatai Oladunni, Chengjin Ye and Kevin Chiem.


Texas Biomed is one of the worlds leading independent biomedical research institutions dedicated to eradicating infection and advancing health worldwide through innovative biomedical research. Texas Biomed partners with researchers and institutions around the world to develop vaccines and therapeutics against viral pathogens causing AIDS, hepatitis, hemorrhagic fever, tuberculosis and parasitic diseases responsible for malaria and schistosomiasis disease. The Institute has programs in host-pathogen interaction, disease intervention and prevention and population health to understand the links between infectious diseases and other diseases such as aging, cardiovascular disease, diabetes and obesity. For more information on Texas Biomed, go

Excerpt from:
Texas Biomed with the University of Alabama at Birmingham and Aridis Pharmaceuticals develop a neutralizing human monoclonal antibody against...

OCNI congratulates the Centre for Canadian Nuclear Sustainability (CCNS) on the opening of its Innovation and Collaboration Space in Pickering -…

PICKERING, Ontario, Oct. 23, 2020 (GLOBE NEWSWIRE) -- The Organization of Canadian Nuclear Industries (OCNI) is proud to congratulate Ontario Power Generation on the opening of its Centre for Canadian Nuclear Sustainability CCNS Innovation and Collaboration Space in Pickering Ontario.

OCNI is also pleased to announce that it as signed a Community Partner Agreement of the CCNS under which OCNI will work closely with the CCNS in mobilizing Ontarios strong nuclear supply chain to develop the unique tooling and remote handling systems required for nuclear decommissioning activities.

OCNI, working out of its head office in Pickering just down the road from CCNS Innovation Hub, will use its extensive international network in collaborating with the CCNS to development export opportunities for innovative nuclear decommissioning solutions generated by the CCNS and its partner organizations in the nuclear supply chain.

The Canadian Nuclear Decommissioning Capabilities Catalog being prepared for OCNI will enable the CCNS to identify unique decommissioning competencies across the Canadian supply chain for deployment on OPGs Pickering decommissioning project as well as on offshore decommissioning projects, said OCNI President and CEO, Dr. Ron Oberth.

The CCNS welcomes OCNI as a community and industry partner and looks forward to engaging with OCNI and its many member companies who have developed unique capabilities in reactor deconstruction and nuclear materials management through work on refurbishment and life extension projects on CANDU reactors at Darlington, Bruce, Argentina and South Korea, added Carla Carmichael, OPGs Vice President of Decommissioning Strategy and lead for the CCNS. With its long history and experience, the Canadian nuclear supply chain is well poised to lead and advance innovations in the next phase of the nuclear lifecycle.

Organization of Canadian Nuclear Industries (OCNI) is an association of more than 220 Canadian suppliers to the nuclear industry that employ more than 15,000 highly skilled and specialized engineers, technologists, and trades people. OCNI companies design reactors, manufacture major equipment and components, and provide engineering services and support to CANDU nuclear power plants in Canada as well as to CANDU and Light Water Reactor (LWR) plants in offshore markets.

Follow this link:
OCNI congratulates the Centre for Canadian Nuclear Sustainability (CCNS) on the opening of its Innovation and Collaboration Space in Pickering -...

Bentley Systems Announces Winners of Year in Infrastructure 2020 Awards – Business Wire

EXTON, Pa.--(BUSINESS WIRE)--Bentley Systems, Incorporated, (Nasdaq: BSY), the infrastructure engineering software company, has announced the winners of the Year in Infrastructure 2020 Awards. The annual awards program honors the extraordinary work of Bentley users advancing design, construction, and operations of infrastructure throughout the world.

Sixteen independent jury panels selected the 57 finalists from over 400 nominations submitted by more than 330 organizations from more than 60 countries.

Bentley Systems acknowledged 19 Year in Infrastructure 2020 Awards winners and 14 Special Recognition awardees on October 21 during the Year in Infrastructure 2020 Conference, held virtually for the first time. To see the Year in Infrastructure 2020 Awards finalists present their projects, click here.

The Year in Infrastructure 2020 Special Recognition awardees are:

Advancing Project and Asset LongevityHDRMarc Basnight BridgeDare County, North Carolina, United States

Advancing Bridge Asset Performance ModelingUlsan National Institute of Science and Technology (UNIST)A Smartwatch on the BridgeUlsan, Ulju-gun, South Korea

Advancing Industrial Asset Performance ModelingThe Institute of Engineering and Ocean Technology/Oil and Natural Gas Corporation LimitedChallenges in Addressing Life Extension of Ageing Platforms in Western Offshore of IndiaMumbai, India

Comprehensiveness in Industrial Digital TwinsVolgogradnefteproekt, LLCEthane-Containing Gas Processing Complex Construction SupportUst-Luga, St. Petersburg, Russia

Comprehensiveness in Transportation Digital TwinsPT. WASKITA Karya (Persero) TbkRailway Facility for Manggarai to Jatinegara: Package A - Phase II ( Main Line II )South Jakarta, Jakarta, Indonesia

Comprehensiveness in Urban Digital TwinsJSTI Group Co., Ltd.Hengjiang Avenue Rapid Transformation ProjectNanjing, Jiangsu, China

Comprehensiveness in a Connected Data EnvironmentRoads & Transport Authority (RTA)Collaborative Information System Implementation - Whole Lifecycle Common Data EnvironmentDubai, United Arab Emirates

Advancing Virtualization through Digital TwinsNetwork RailOvercoming Challenges Under COVID-19 LockdownWales and Western Region, United Kingdom

Advancing Model-based Delivery through Digital TwinsNYS Department of TransportationModel Based Contracting - NYS RT 28 over the EsopusMount Tremper, New York, United States

Advancing Mixed-Reality WorkflowsLiaoning Water Conservancy and Hydropower Survey and Design Research Institute Co., Ltd.Chaoyang Underground Pumping Station Project of the LXB Water Supply Project Phase IIChaoyang, Liaoning, China

Advancing Sustainability Digital TwinsShanghai Institute of Mechanical and Electrical Engineering Co., Ltd.Shanghai Electric Environmental Protection Group Technology Renovation and Expansion Project for Nantong Thermoelectric Waste IncinerationNantong, Jiangsu, China

Advancing Sustainable ArchitectureSwatch Ltd., Shigeru Ban, Itten+Brechbhl AGSwatch HeadquartersBiel, Bern, Switzerland

Advancing Sustainable EnergyGuangdong Hydropower Planning & Design InstituteGuangdong Yangjiang Pumped Storage Power StationYangjiang, Guangdong, China

Advancing Sustainable WaterJacobsSan Jose HeadworksSan Jose, California, United States

The winners of the Year in Infrastructure 2020 Awards for going digital advancements in infrastructure are:

4D Digital ConstructionDPR Construction2019 LSM DS Tech UpgradeDurham, North Carolina, United States

BridgesChongqing Communications Planning, Survey & Design Institute Co., Ltd.,Guizhou Communications Construction Group Co., Ltd.,Guizhou Bridge Construction Group Co., Ltd.Digital Design and Construction of Taihong Yangtze River BridgeChongqing, China

Buildings and CampusesVoyants Solutions Private LimitedBangladesh Regional Waterway Transport Project 1 Shasanghat (New Dhaka) IWT TerminalDhaka-Shasanghat, Narayanganj, Chandpur, and Barisal; Bangladesh

Digital CitiesCity of HelsinkiDigital City of SynergyHelsinki, Finland

Geotechnical EngineeringGolder Associates Hong Kong Ltd.Tuen Mun-Chek Lap Kok Link Tunnel, Southern LandfallHong Kong

Land and Site DevelopmentAAEngineering GroupDzhamgyr Mine - Project Implementation in Extreme ConditionsTalas Region, Kyrgyzstan

ManufacturingMCC Capital Engineering & Research Incorporation Ltd.BIM Technology-Based Construction of Digital Plant for Iron & Steel Base in Lingang, Laoting of HBIS Group Co., Ltd.Tangshan, Hebei, China

Mining and Offshore EngineeringAAEngineering GroupDigital Twin of AKSU Plant: From Concept to StartupAksu, Akmola Region, Kazakhstan

Power GenerationShanghai Institute of Mechanical and Electrical Engineering Co., Ltd.Shanghai Electric Environmental Protection Group Technology Renovation and Expansion Project for Nantong Thermoelectric Waste IncinerationNantong, Jiangsu, China

Project DeliverySwecoSweco | Digitalisation with BIMUnited Kingdom

Rail and TransitPOWERCHINA Huadong Engineering Corporation LimitedInnovative Application of Digital Engineering Technology in Shaoxing Rail and Transit ConstructionShaoxing, Zhejiang, China

Reality ModelingKhatib & AlamiGeo-enabling Reality Model Tips and TricksMuscat, Oman

Road and Rail Asset PerformanceRoads and Transport Authority (RTA)Collaborative Information System Implementation - Whole Lifecycle Common Data EnvironmentDubai, United Arab Emirates

Roads and HighwaysSichuan Road & Bridge (Group) Co., Ltd.BIM Technology Application on Chengdu-Yibin ExpresswayChengdu, Sichuan, China

Structural EngineeringWSPWSP Overcomes Complex Challenges with Bentleys Technology to Deliver Principal TowerLondon, England, United Kingdom

Utilities and CommunicationsSterlite Power Transmission LimitedSterlite BIMTripura, India

Utilities and Industrial Asset PerformanceShells QGC businessEvolution of Engineering Data, Documents and Information ManagementBrisbane, Queensland, Australia

Water and Wastewater Treatment PlantsHatchAshbridges Bay Treatment Plant OutfallToronto, Ontario, Canada

Water, Wastewater, and Stormwater NetworksDTK Hydronet SolutionsDigital Water Network Engineering & Asset Management of Dibrugarh Water Supply ProjectDibrugarh, Assam, India

All awards finalists and winners

Detailed descriptions of all nominated projects are in the print and digital versions of Bentleys 2020 Infrastructure Yearbook, which will be published in early 2021. To review the past editions of this publication, access Bentleys Infrastructure Yearbooks.

Image: YII 2020 Awards Trophy and Yearbook

Caption: All Year in Infrastructure 2020 Award winners, finalists, and nominees will be featured in the 2020 Infrastructure Yearbook, which will be published in early 2021.

About Bentley Systems

Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the worlds infrastructure sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annual revenues of more than $700 million, in 172 countries.

2020 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, and ProjectWise are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.

Here is the original post:
Bentley Systems Announces Winners of Year in Infrastructure 2020 Awards - Business Wire

Chrysal International and Verdant Technologies Announce Partnership – PerishableNews

ST. PAUL, Minn. Chrysal International is announcing a partnership with Verdant Technologies to bring a step change solution to the floral industry. This new product, a 1-MCP-based solution, will be available across the industrys international markets with initial focus on Colombia, one of the largest floral growers in the world, and Miami, one of the largest receiving areas in the United States for floral products.

Chrysal International is committed to offering innovative solutions for the floral supply chain, from growers to consumers. Through our partnership with Verdant Technologies, we are expanding our product offering to our customers and are able to explore new possibilities in the industry. It is exciting for us to be part of this new venture, said Peter Vriends, CEO of Chrysal International, the worldwide market leader in flower food and post-harvest flower and plant care.

For Verdant Technologies, an emerging leader in the biotechnology industry, a partnership

with Chrysal is an exciting introduction of HarvestHold to the floral market segment.

Chrysal has a long history of providing premium flower care products with proven results for growers, packers, supermarkets, florists and consumers. This along with Chrysals mission to reduce waste in the horticultural supply chain make their partnership a natural fit, said Gordon Robertson, Chief Revenue & Marketing Officer of Verdant Technologies.

Chrysal and Verdant Technologies are actively working together to bring a patented 1-methylcyclopropene (1-MCP) based solution to market that delivers superior stability, efficacy and consistency throughout the horticultural supply chain.

1-MCP has proven to be an effective tool to extend the quality of fresh cut flowers and potted plants to date, said Jon Fobes, President of Verdant Technologies. What Chrysal and Verdant are developing is a shelf-stable solution and superior delivery method for 1-MCP. Our product is extremely reliable, easier to store, does not require wetting and can be applied where it is needed throughout the supply chain process.

Chrysal and Verdant Technologies have focused their technologies around the 1-MCP products flexibility, which will allow Chrysals global customer base of growers and packers to spend more time getting more product to market and lessen the impact of horticultural wastage.


Chrysal is a global company. The flexibility of our product makes it a global product with the reach and ability to be applied anywhere in the world at any step of the supply chain process, said Robertson. We have ideas. Chrysal is aware of the challenges in the industry. By working together, we can solve the immediate needs of their customers and develop future solutions to make the global floral industry more efficient, sustainable, and deliver better quality products.


About Verdant Technologies

Verdant Technologies is an emerging leader to the biotechnology industry, offering HarvestHold product life extension technology for floral and produce products. Verdant Technologies and its partners work hand-in-hand to reduce negative environmental impacts while delivering fresher, more nutritious produce and enhanced florals to more people in more places. Verdant Technologies has corporate offices in St. Paul, Minnesota. For more information,

About Chrysal International

Chrysal is a main driving force in the flower and plant industry and worldwide market leader in flower food and post-harvest flower and plant care. Whether you grow, transport, sell, or simply enjoy the beauty of cut flowers and potted plants in your own home, Chrysal has products to keep them looking fresh for longer. Through more than 85 years of experience and innovation, a commitment to quality and an on-going search for sustainable solutions, we aim to meet our customers needs today and tomorrow. The result? Flowers and plants that last longer, happy customers and, in the end, a more beautiful world.Chrysal. Nurturing beauty.For more information about Chrysal International,

Original post:
Chrysal International and Verdant Technologies Announce Partnership - PerishableNews

Impact of COVID-19 on Black Cumin Seed Oil Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Henry Lamotte OILS GmbH, FLAVEX…

Black Cumin Seed Oil Market research report is the new statistical data source added by A2Z Market Research.

Black Cumin Seed Oil Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Black Cumin Seed Oil Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Key Players Profiled in this report are:

Henry Lamotte OILS GmbH, FLAVEX Naturextrakte GmbH, Henry Lamotte Oils GmbH, Kerfoot Group, Earthoil Plantations, Life Extension, Nuverus, Omega Pharma, BioPraep,

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Black Cumin Seed Oil market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Black Cumin Seed Oil markets trajectory between forecast periods.

Get up to 30% Discount on this Premium Report @:

The cost analysis of the Global Black Cumin Seed Oil Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

Reasons for buying this report:

Table of Contents

Global Black Cumin Seed Oil Market Research Report 2020 2026

Chapter 1 Black Cumin Seed Oil Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Black Cumin Seed Oil Market Forecast

Buy Exclusive Report @:

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith



+1 775 237 4147

Follow this link:
Impact of COVID-19 on Black Cumin Seed Oil Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Henry Lamotte OILS GmbH, FLAVEX...

Drilling contract seen as an N.L. oil industry win following a series of pandemic setbacks –

The province's oil and gas association is heralding anew drilling contract in the Flemish Pass as a rarevictory for the struggling Newfoundland and Labrador offshore oil industry.

CNOOC Petroleum North America is set to create a single exploration well in the area next spring.

"It is certainly positive news for our industry and for the supply and service sector that Noia represents," said Charlene Johnson, chief executive officer for the Newfoundland and Labrador oil and gas industries association.

The Chinese company has contracted U.K.-based Stena Drilling Ltd. to drill the Pelles A-71 well, with work starting between April and June2021, and lasting for some 90 days.

The company will use the Stena Forth, a harsh-environment drill ship capable of drilling in water depths up to 3,000metres. The campaign will create roughly 370 direct and indirect jobs, said Johnson, and inject tens of millions into the province's economy.

It's the latest step in efforts to expand oil production beyond the four producing fields in the Jeanne d'Arc Basin.

But it's the only exploration activity planned for next year, despite some $4 billion in exploration commitments having been made by oil companies in recent years.

The global pandemic has threatened that activity, and industry boosters are hoping CNOOC's continued confidence in the offshore will motivate other oil majors to take similar action.

"We would love to see more than one well being drilled next year," said Johnson.

Johnson is hoping thata program announced by the provincial government last month will encourage companies like CNOOC, BP and others to drill more wells in frontier areas like the Flemish Pass and the Orphan Basin intheir quest to find the next big discovery.

The province has promised to provide cash to companies to help defer the cost of an exploration well, which can cost up to $100 million each.

The money will come from downpayments made by companies on exploration projects that have been defaulted because the work was not done in a specified period of time, typically six years.

A company must hand overa 25 per cent down paymentonwork commitments to the offshore petroleum board when it is awarded exploration rights on a land parcel. As such, the board is now holding roughly $1 billion in cash from oil giants like ExxonMobiland BP.

Under this new program, if companies forfeit that cash, the province will use it to entice other companies to drill wells.

It's conceivable that up to $46 millionin security payments could become available next year alone, with thatfigure steadily increasing in future years.

The province is still working out the details of how companies can access these funds, and no approvals have yet been made.

In a statement to CBC News, an official with the Department of Industry, Energy and Technology said CNOOC is "very interested" in the program.

Johnson is hoping the program will be the incentive needed for CNOOC to do a second or even a third exploration well next year.

But she said it's vital for the province to reveal the program parameters as soon as possible so companies can have some certainty.

"That may have an impact in terms of influencing the number of wells next year if it's attractive enough," she said.

CNOOC has a 100 per cent working interest in two exploration licenses, and has described the area it plans to explore as "world-class" with a "large hydrocarbon potential."

The company has already acquired 3D seismic information on the area it plans to drill, andhas said it aims to "build long-term, sustainable success in the region."

CNOOC had planned to drill what's known in the business as a wildcat well this past spring and summer in the same area, using the Stena IceMax at a reported daily fee of $299,000.

But that campaignwas shelved because of thepandemic.

It was one of a long list of setbacks that have rocked the oil industry this year.

With oil prices cratering this past spring because of a combination of the pandemic and an oil price war between Russia and Saudi Arabia, oil companies began slashing spending.

Drilling on the Hibernia platform and work on a series of extension tiebacks have been suspended, a long-planned life extension project for the Terra Nova FPSOis under review, Equinor's Bay du Norddevelopment has been deferred, and the West White Rose extension project is stalled at roughly 60 per cent completion.

As a result, the industry has been shedding jobs in large numbers, and the supply and service sector is reeling, said Johnson.

With climate changes worries as a backdrop, there's widespread agreement that the transition away from hydrocarbons will occur in the coming decades in order to reduce greenhouse gas emissions.

That's why it's vitally important that exploration drilling is intensified, said Johnson, so the province and its citizens can benefit from the resource before it's too late.

The sooner new discoveries are made, she said, the sooner construction on new oil producing platforms would commence.

Read more from CBC Newfoundland and Labrador

Excerpt from:
Drilling contract seen as an N.L. oil industry win following a series of pandemic setbacks -

Global Oral Probitoics Market 2020 Trends Analysis and (COVID-19) Effect Analysis | Key Players Market With COVID-19 Impact Analysis | In Depth…

Global Oral Probitoics Market Report Details Out Market Overview, Market Valuation, And Future Market Prospective

The Oral Probitoics markets growth and development is significantly skyrocketing due to the current modernization and innovative futuristic scopes. TheOral Probitoics marketreport mentions all the details regarding the latest techniques that are followed in order to meet the customers demand and supply. Some of the most important and intricate data including the market share, supply and demand statistics, growth factors, and investment dynamics are mentioned in such a clear format that the clients can grab the growth and development facets from the dossier for a piece of better global market knowledge. The current report helps open new doors for the global Oral Probitoics market. Some of the vital players NatureWise, Now Foods, DS Healthcare, Higher Nature, NutriPreme, Candidabiotix, Hyperbiotics, Jarrow Formulas, Life Extension, Natren, UltraCruz, Aqua Flora that are at present dominating the global platform include.

Click here for the free sample copy of the Oral Probitoics Market report

Key objectives that motivate the procurement of this report:-

To study and analyze the global valuation (size, revenue,& volume) based on key regions/countries, product type, application, and history data To understand the breakdown structure of Oral Probitoics market Studying the market valuation, competitive landscape, and recent development plans help gain better insight of the market Analyzing ample information such as opportunities, drivers, industry-specific challenges and risks that prompt the Oral Probitoics market growth To study competitive advances such as expansions, agreements, new product launches, and acquisitions, mergers among the key market players To analyze the strategic business strategies and its impact on the market growth rate

The informative research report has summarized even the government stringent rules and regulations, market segmentation, and expert practices. The transparency portrayed in the current dossier is bliss for both clients and other business players. Along with the current and forecast trends, even the historical details are penciled down for grasping a better outlook of the entire market on a global scale. The most important part is the regional segmentation North America (United States, Canada and Mexico), Europe (Germany, UK, France, Italy, Russia and Turkey etc.), Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) of the Oral Probitoics market as the scale of growth across the globe can easily be depicted and understood.

Read Detailed Index of full Research Study at::

An Overview About the Table of Contents:

Global Oral Probitoics Market Overview Target Audience for the Oral Probitoics Market Economic Impact on the Oral Probitoics Market Global Oral Probitoics Market Forecast Business Competition by Manufacturers Production, Revenue (Value) by Region Production, Revenue (Value), Price Trend by Type Market Analysis by Application Cost Analysis Industrial Chain, Sourcing Strategy, and Downstream Buyers Marketing Strategy Analysis, Distributors/Traders Market Effect Factors Analysis

The Oral Probitoics market report has a paragraph dedicated to the market segmentation {Lozenges}; {Human Use, Veterinary} mentioned in a bifurcated form for an easy grip on the global market. From the current contextual report, the clients get knowledge about the trade and industry, stringent industrial practices, profit and loss statistics, growth benefits, product demand and supply, economic fluctuations, and future market scope. The current research report basically aims towards only providing the customers with the entire market study and ongoing trends with just a single click in a simple and brief format.

Enquire Here Get customization & check discount for report@

Why Choose Market Data Analytics reports?

Our analysts use latest market research techniques to create the report Market reports are curated using the latest market research and analytical tools Customization of report is possible as per the requirement Our team comprises of expertise and highly trained analysts Quick responsive customer support for domestic and international clients

See the rest here:
Global Oral Probitoics Market 2020 Trends Analysis and (COVID-19) Effect Analysis | Key Players Market With COVID-19 Impact Analysis | In Depth...

Timothy Leary Turns 100: Americas LSD Messiah, Remembered By Those Who Knew Him – VICE UK

By some accounts, Timothy Leary is the most productive and prolific evangelist for psychedelic drugs in human history. At the height of the 1960s counterculture, he was a prophet (or a pied piper, depending on who you ask) who inspired millions of young people to take LSD and go out of their minds.

He coined a mantra, Turn On, Tune In, Drop Out, which was adopted as a PR slogan and a life philosophy for scores of hippies. He sparked and featured in classic works by The Beatles, The Who, Allen Ginsberg and The Moody Blues. He was also a womanizer and a brazen narcissist, as well as an IQ-tested genius. President Nixon reportedly called him the most dangerous man in America.

Though he died 24 years ago, in 1996, there may be no better time to consider Timothy Learys life and legacy. Thousands are turning on to the psychedelic renaissance every year, and when they dive deeper into the LSD wormhole theyll no doubt land on Learys name as one of the guys responsible for it all.

As a clinical psychologist at Harvard University, Leary worked on the Psilocybin Project with his colleague and friend, Richard Alpert, and a close circle of graduate students. Their controversial studies aimed to demonstrate the therapeutic and mystical applications of psychedelics, but Leary and Alpert were eventually fired amid allegations they had pressured students into taking hallucinogens. Leary later took his studies to the Millbrook Estate, a 64-room mansion in New York, where he and a communal group freely experimented with LSD and spiritual practice.

By the end of his life, Leary had left a sizeable mark on American culture. He had influenced psychedelic rock, the hippie trail, spiritual seekers, Steve Jobs, Silicon Valley, painters, poets and the very scientists leading the psychedelic renaissance today. At the same time, Leary's careless peddling of LSD as an intense aphrodisiac it could give women several hundred orgasms, he claimed and something children could enjoy dealt sometimes life changing blows. Many under Leary's influence were guided on voyages from which they never returned.

On what would have been the month of his 100th birthday, VICE presents an oral history of Timothy Learys long, strange trip, via interviews with those who knew, loved and hated the man.

Interviews have been edited for length and clarity.

1955: Leary wasnt always drawn to drugs. He started his career as a strait-laced psychologist who researched personality theory and preferred Martini and red meat to pills. But something was missing. Things came to a head in 1955 when his first wife took her own life on his 35th birthday, leaving Leary a single father to two young children.

He had a traumatic childhood, too, with an abusive father, an absent mother and a conman grandfather rendering him deeply suspicious of authority figures. It seems a rebellion was only a matter of time. Robert Forte, the author of Outside Looking In and a longtime friend of Learys, shares more:

When Frank Barron [a psychologist and friend of Learys] first told him about psychedelic drugs, Tim said, I'm not going anywhere near that ship. And I think you should stay away from it, too, Frank.

He had to talk Tim into it. It took a year for Frank to convince him to do it. But also, Tim was very against authority, and there was a lot of it in the 1950s in American society. When you put him in with an authority figure, he would kind of go nutty. That was the way his psyche was set up since he was a young boy.

I found some letters that Tim wrote to his mother when he was at West Point [school], about what his goals in life were. He just wanted to have a good time. He wanted to be famous. He just wanted to have a normal, healthy, happy life.

Summer, 1960: Leary has his first psychedelic trip in Cuernavaca, Mexico, with psilocybin mushrooms. The trip is a life-changing experience. It was in Cuernavaca that he met Michael Maccoby, a psychology researcher who'd just left Harvard.

Tim had asked me if I wanted to experience hyperconsciousness. I said, Tim, theres white magic, and theres black magic. Black magic is when you get something and pay the price later. White magic, you do the work first.

Autumn, 1960: Leary returns to Harvard and re-acquaints himself with Richard Alpert, a faculty member who would become his right-hand man in psychedelic research, and eventually rechristen himself as Ram Dass. Leary and Alpert found the Harvard Psilocybin Project, a pioneering programme of studies into psilocybins potential to map the fineries of human consciousness.Don Lattin, author of The Harvard Psychedelic Club and Changing Our Minds, remembers the Harvard Psilocybin Project:

It was revolutionary from the beginning. From the very, very beginning. They were never really doing the serious clinical trials with psychedelics that had already been happening in the 1950s. No, they had a whole other idea, an agenda.

[From his first trip], Leary was convinced that psychedelics were going to revolutionise the practice of psychology, psychiatry, and change the world.

Elliot Aronson was a Harvard faculty member they contacted for advice:

The [first] major time I heard about psilocybin was at a lunch with Alpert and Tim. Tim was talking in a rather grandiose way about all that psilocybin could accomplish. And so I made a snide crack: All that from a little mushroom? or whatever it was he had in his hand.But he was serious. And he didn't like my joking about it. And he was right. It was a powerful little mushroom, a powerful little pill.

1962: Leary and his colleague Walter Pahnke devise the Marsh Chapel Experiment, to test psilocybins ability to trigger religious experiences. Leary and the graduate students also dose themselves with the drug. Reverend Randall Laakko looks back on the test as a participant:

I got down to the door and I busted out of there and went out into the side yard of the chapel. And Leary came out after me. I just wanted to immerse myself in life and the world. I buried my face in the shrubs and I took a big bite out of the leaves. They were very bitter. I probably spat them out.

When we were starting to come down, I lay on the floor for a while. Leary was laying right beside me. I remember the smell of his hair. I reached on to his body with my hand, and he took it gently. It was just a sense of oneness with everything.

Allan Cohan, a member of Learys Harvard circle, says: Interestingly, all of this is now being rediscovered by psychologists at Johns Hopkins University, for example, who are using psychedelics for depression, for end of life experiences, etc. I wish they'd consulted us. We could have saved them a lot of time.

Towards the end of 1962, Leary and the Harvard group begin to question their aims. They found the International Federation for Internal Freedom (or IFIF) to support their research.Paul Lee, a Harvard theologian, a participant at Marsh Chapel and a member of the Leary circle, reflects on the crews aims:

There was a big discussion about whether to go underground with it and make it a kind of secret initiation issue, or go public. But Leary was an Irish revolutionary and he wanted to shout it from the rooftops. So it went that way. It simply became a tsunami.

As Leary and Alpert evangelised other faculty members, some tried it and had terrible experiences, remembers Allan Cohan. But Leary, when faced with that even when we had a suicide or two said, Well, in the exploration of outer space, you're going to lose some astronauts. Same with inner space. There was a lot of care and concern from Alpert. But Leary was simply willing to take many more risks.

Herbert Kelman was a department member at the time:

The faculty organised a meeting. It was packed, absolutely packed. I outlined why these drug experiments Leary was conducting were lax in scientific validity. They weren't doing research at all.

We heard of graduate students having mental health issues. There were a couple of students in that class who had bad trips. I can't remember any details, but somebody who was on the brink [anyway] almost tumbled from a window.

1963: After failing to arrive at classes, Learys contract at Harvard is terminated. He seeks the support of benefactors like Peggy Hitchcock, the heiress to the Mellon fortune. She gives Leary and his circle a sprawling estate, Millbrook, from which to conduct further research.

When I first met Tim, I thought he was one of the most interesting people I'd ever met, says Peggy Hitchcock. I thought he was absolutely fascinating. I fell in love with him quickly, and we had a funny kind of swinging door relationship. But his relationship with his kids convinced me we couldnt be together.

He tried to be a good father. But really, when he got involved with psychedelics and everything, I mean, he really wasn't. Teenagers need a parent. He wasn't able to be there for them. [Tims] daughter later committed suicide in jail and his heart was really trashed. His son never, never spoke to him again. Hardly.

Years later [in 1992], when we reconnected, we spent most of the night talking. He was staying at a hotel. And that was as close as I ever got to his talking to me about the sadness in life.

1963-66: Millbrooks early years are promising. Publishing research, holding talks and staging retreats, it places emphasis on integration and non-drug-related spiritual practice. Leary founds his own religion, The League for Spiritual Discovery, which holds LSD as its primary sacrament. Bill Richards, who now works as a psychedelics researcher at John Hopkins, looks back on those days at Millbrook:

It was fun. It was loose. It was a little bit chaotic, but it was warm and genuine and playful and open to new ideas, you know, and appreciative of the transcendental state of consciousness. The seminars I attended there were really very sober, academically-oriented workshops. So, you know, Millbrook wasn't just a bunch of crazy hippies having a party.

This would change. Returning from a trip to India, Leary found that Millbrook had descended into a psychedelic squat.Ted Druch, who lived in an ashram on the Millbrook site, remembers how out of control things got:

Millbrook was a gold rush. But with Timothy Leary and acid instead of gold. There were horses painted psychedelic colours running through the woods. Girls were running around naked, fucking everything in sight. Tim Leary had an aura. But he really was an asshole.

We ended up having a huge fight with Leary. He was into this God will provide, everything will provide. Everything will come. You never have to worry about anything kind of attitude. Except the problem was that we didn't have money to put oil in the furnace. His daughter even fled and moved into our ashram. We gave her a room, and she spent the next five days in her room crying.

Over the course of two years, things went from bad to worse. The cops got involved. Dutchess County was a Republican stronghold and we went through about a year of constant raids.

Vanessa Hollingshead is the daughter of Michael Hollingshead, the man who first gave Leary LSD:

I never liked living at Millbrook Mansion. Most of the time, Leary, my dad, hippie men and women, everyone, was on something.

I [accidentally] did between nine and 19 hits of acid at five years old. I didn't even know what was going on. It was on sugar cubes. I was jumping up and down on a trampoline and all of a sudden I looked down and I just saw all these coloured fluorescent worms. I started screaming and Britta [my dads girlfriend] grabbed me off the trampoline. I remember them holding me up and giving me a shot of [the anti-psychotic medicine] Thorazine right in the behind.

1967: Alpert leaves for India, where he met his guru. Leary moves to the West Coast and finds a largely receptive audience among the burgeoning hippie movement. It was at the historic Human Be-In in San Francisco in January of that year where Leary coined his famous mantra, Turn on, tune in, drop out, remembers Jay Stevens, the celebrated author of Storming Heaven__**:**

[In Tim], LSD found the perfect salesman: charming, personable, able to coin phrases. He was an advertising genius in a way. He could have made a lot of money in advertising.

Eugene Schoenfeld was Learys personal physician at the time:

I remember the moment when Tim came out with the 'turn on, tune in, drop out' slogan. A lot of young people followed his advice and dropped out. In fact, I said to him a little bit afterwards, 'You've got a PhD. I have a medical degree. And all these kids are dropping out of college. You know, is this good? He just shrugged it off. It was a great slogan. But, I mean, he would take acid before giving public talks. So sometimes, unless you were in the same state, it just seemed like gibberish, you know?

Bill Richards has other thoughts:

I think it should be Turn on, tune in, jump in work within the structures of society to change them.

James L Penner, the author of Timothy Leary: The Harvard Years__**, says Learys famous slogan has been misread:**

It's not simply drop out of society and never pay attention to politics or anything, and go be a hermit. He asks us to drop out of the games we play. I'm playing the professor game. You're playing the journalists game. He was playing the Timothy Leary game all the time himself. And psychedelics allow you to step back from the game and question it, deflate it, not take it so seriously.

1967: Learys advocacy for psychedelic drugs reaches fever pitch during the 1967 Summer of Love. He is adopted as the spiritual leader of the Brotherhood of Eternal Love, a drug ring that manufactured Orange Sunshine, the world-famous acid strain that fuelled the counterculture.

Michael Horowitz was Learys close friend and personal archivist:

I and at least 5 million other people can say that we would never have taken LSD if it weren't for Tim Leary. He used to quip later in his life, I turned on 5 million people and only 5,000 ever thanked me.

In the history of every religion, it's the priests who controlled the sacraments, whatever the sacrament happened to be. In the mid-20th century, the priests were the psychiatrists. Leary was a psychologist who became a shaman.

Norman Watt was Learys replacement at Harvard. A researcher in schizophrenia, he became acquainted personally with the costs of Learys revolution.

I met many [casualties]. I treated them in hospitals and veterans hospitals in California and Ohio and elsewhere. There were so many. And the research was still beginning. Its only in the decades since that weve learnt about how LSD impacts the nervous system of human beings. It's all come out since then.

James Kent, a psychedelic thinker and host of the Dose Nation podcast, reflects on Learys negative impact:

How dangerous was Tim? I don't think he was Manson dangerous. But he helped make Manson, no doubt. There would be no Charlie Manson without Tim Leary.

1970: The War on Drugs is launched. LSD is made federally illegal and many promising avenues in psychedelic research are banned.Rick Doblin, founder of the Multidisciplinary Association for Psychedelic Studies, says:

Learys reputation is pretty low [among psychedelic scientists]. I think that a lot of people blame him for the crackdown. But I really think the crackdown on psychedelics happened because psychedelics were going right. They motivated people to get involved in social justice activities, protests. And Tim did a lot of good work generating people to have those kinds of experiences. I think, on balance, he did way more good than harm. Though I fault him for twisting the data in his studies.

Robert Forte agrees:

Well, it's such bullshit. He didn't ruin research. Yeah, he was outrageous. But I mean, the government was the one that fucking ruined research with their idiotic move. How come nobody is saying that? Tim didn't just tell people to take psychedelic drugs. The most continuous message throughout his whole life was to question authority and think for yourselves.

After running for Governor of California during which he got The Beatles to write Come Together as his campaign song Leary is arrested in 1970 on drug charges after two stubbed roaches are found in his car ashtray. He is sentenced to ten years in jail.

He didn't do anything, nothing, to ingratiate himself with any kind of establishment, says Peggy Hitchcock. He didn't care. And so, of course, when they arrested him, that was just the way it was going to happen. I kind of knew it was going to happen. It was a question of time. No one can say 'Fuck you' to everybody all the time. It just doesn't work.

Leary escapes from jail and is shipped by a radical left wing group, The Weather Underground, to Algeria. He makes his way to Switzerland and lives in exile, but is captured in 1973 and taken back to the USA by the CIA. He faces nearly a century behind bars.

I knew Joanna Harcourt-Smith [Tims new wife] very well, remembers Eugene Schoenfeld. But when she moved to San Francisco, I noticed that she would be asking questions about people's drug habits, for example. And one time she asked me how she could obtain a large quantity of LSD. It just didn't seem right. As it turned out, Joanna was scooping up the information because she and Timothy were cooperating with the federal government.

When I first heard the rumours, I didnt believe it. When I found out? Shock, dismay, disappointment. Yes, all those things. I visited Tim in prison. He certainly did not have a posh cell like some of the Mexican drug lords had in their prisons, but he was protected, I think, especially after he began cooperating with the feds.

I really just reduced my contact with him greatly [after this].

Doug Rushkoff, a writer and later friend of Learys, is more balanced:

Towards the end [of his life], a lot of journalists were really getting into whether or not he had turned in the Weathermen to the CIA. And he was a little upset by that. But he told the CIA stuff only what they already knew or stuff that was no longer current. And, you know, there are always these efforts to recast heroes.

1976: After his early release from prison in 1976, Tims work moves to other areas: space exploration, life extension and, predominantly, computers and technology.

You've got to understand that his work with psychedelics was sort of like a greatest hit, says Zach Leary, Tims son. You go see a rock and roll band play their hit single, but their career is about so much more than that. And that was very much the same with him. Tune in, turn on, drop out, the psychedelic years, were really just one step on a much larger path and a much larger vision.

Anytime somebody came around who was really trying to wax nostalgic about [that time], he would get really feisty. He'd say, 'Hey, man, that's the past. You're on some old trip, man. It's not 'tune in, turn on, drop out' anymore. Its 'turn on, boot up, jack in' now."

From the 80s onward, he saw technology as the next psychedelic, the new LSD, recalls Doug Rushkoff. He believed that that digital would be as powerful or more powerful, and plus you don't have to eat it. They just log on.

1996: At 75 years old, on the 31st of May, Leary dies in the Hollywood Hills. Amid the growth of early PC and cyberpunk culture, he had enjoyed a resurgence in popularity.

I remember the day he died, says Zach. We all knew that was going to be the day. I was very clear. We were being guided by Ram Dass [Alpert] on the telephone.

Doug Rushkoff was there, too. In the last half hour or so of his life, he started to say, 'Why not?' And he repeated 'Why not?' in all these weird ways. 'Why not? Why not? Why not? Why not?' 'Why not die?' he was suggesting. 'You know, this is it.' And in life, when someone is telling you not to do something, ask 'Why not?' That's the core question.

2020: Early reports suggest that psychedelic use has increased considerably amid the pandemic lockdown. Doug Rushkoff wonders what Tim would have thought.

He was saying 'tune in, turn on' and all that, but he was painfully aware of the downside to people doing psychedelics in the wrong set and setting without proper tutelage.

But, I mean, of course he'd be happy that maybe it took a pandemic and the crash of capitalism or something for people to have the safe time and space to explore and seize the opportunity. You know, it's like, 'Oh, wait a minute, I'm going to be alone in my house or in my apartment with my girlfriend for the next month. Let's take acid and fuck a lot.' I don't think he would think that's a bad thing. It's a sacred thing.

James L. Penner agrees: He would have advocated tripping during a time of popular upheaval and political unrest like today. No doubt. Think of the cataclysms of the 60s and how often he tripped then. I mean, he was optimistic to a fault. He always felt that tripping could provide insight and a life-changing experience like the one he had [in Mexico].


View original post here:
Timothy Leary Turns 100: Americas LSD Messiah, Remembered By Those Who Knew Him - VICE UK

New Comprehensive CBD Alternative from Life Extension, Introducing Endocannabinoid Support, without THC or Hemp – Yahoo Finance


Theres so much going on in the markets, that its hard to know where to start and what to look for. On the red side of the ledger, its clear that the headwinds are gathering. House Democrats are still rejecting the $1.8 trillion coronavirus aid and stimulus package put forth by the White House, saying that President Trumps proposal does not go far enough. The House Dems are pushing their own $2.2 trillion stimulus. At the same time, both Eli Lilly and Johnson & Johnson have paused their coronavirus vaccine programs, after the latter company reported an adverse event in early trials. This has more than just investors worried, as most hopes for a return to normal hang on development of a working vaccine for the novel virus.And earnings season is kicking off. Over the next several weeks, well see Q3 results from every publicly traded company, and investors will watch those results eagerly. The consensus is, that earnings will be down year-over-year somewhere between 20% and 30%. With this in mind, weve used theTipRanks databaseto pull up three dividend stocks yielding 6% or more. Thats not all they offer, however. Each of these stocks has a Strong Buy rating, and considerable upside potential.Philip Morris (PM)First on the list is tobacco company Philip Morris. The sin stocks, makers of tobacco and alcohol products, have long been known for their good dividends. PM has taken a different tack in recent year, with a turn toward smokeless tobacco products, marketed as cleaner and less dangerous for users health.One sign of this is the companys partnership with Altria to launch and market iQOS, a heated smokeless tobacco product that will allow users to get nicotine without the pollutants from tobacco smoke. PM has plowed over $6 billion into the product. Given the regulatory challenges and PR surrounding vaping products, PM believes that smokeless heated tobacco will prove to be the stronger alternative, with greater potential for growth.No matter what, for the moment PMs core product remains Marlboro cigarettes. The iconic brand remains a best seller, despite the long-term trend of public opinion turning against cigarettes.As for the dividend, PM has been, and remains, a true champ. The company has raised its dividend payment every year since 2008, and has reliably paid out ever quarter. Even corona couldnt derail that; PM kept up its $1.17 quarterly payment through 2020, and its most recent dividend, paid out earlier this month, saw an increase to $1.20 per common share. This annualizes to $4.80, and gives a yield of 6%.Covering PM for Piper Sandler, analyst Michael Lavery likes the move to smokeless products, writing, We remain bullish on PM's strong long-term outlook, and we believe recent iQOS momentum throughout the COVID-19 pandemic has been impressive. iQOS has had strong user growth and improving profitability, and store re-openings could further help drive adoption by new users.Lavery rates PM shares an Overweight (i.e. Buy), and his $98 price target implies a one-year upside of 24%. (To watch Laverys track record, click here)Overall, the Strong Buy consensus rating on PM is based on 9 reviews, breaking 8 to 1 in Buy versus Hold. The shares are priced at $79.10 and their $93.56 average price target suggests an 18% upside potential. (See PM stock analysis on TipRanks)Bank of N.T. Butterfield & Son (NTB)Butterfield is a small-cap banking firm based in Bermuda and providing a full range of services to customers on the island and on the Caymans, the Bahamas, and the Channel Islands, as well as Singapore, Switzerland, and the UK. Butterfields services include personal and business loans, savings accounts and credit cards, mortgages, insurance, and wealth management.Butterfield saw revenues and earnings slide in the first half of this year, in line with the general pattern of banking services globally the worldwide COVID-19 pandemic put a damper on business, and bankers felt the hit. Earnings in the last quarter of 2019 were 87 cents per share, and by 2Q20 were down to 67 cents. While a significant drop, that was still 21% better than the expectations. At the top line, revenues are down to $121 million. NTB reports Q3 earnings later this month, and the forecast is for 63 cents EPS. Along with beating earnings forecasts, Butterfield has been paying out a strong dividend this year. By the second quarter, the dividend payment was up to 44 cents per common share, making the yield a robust 7%. When the current low interest rate regime is considered the US Fed has set rates near zero, and Treasury bonds are yielding below 1% NTBs payment looks even better.Raymond James Donald Worthington, 4-star analyst with Raymond James, writes of Butterfield, robust capital levels [provide] more than sufficient loss absorption capacity in our view for whatever credit issues may arise. Its fee income stability has proven valuable given the impacts of declining rates on NII, where the bank has actively managed expenses to help support earnings. We continue to believe its dividend is safe for now given its low-risk loan portfolio, robust capital levels, and our forecast for a sub-100% dividend payout even under our stressed outlook.These comments support the analysts Outperform (i.e. Buy) rating, and his $29 price target suggests a 15% upside for the coming year. (To watch Worthingtons track record, click here)Overall, NTB has 4 recent reviews, which include 3 Buys and a single Hold, making the analyst consensus rating a Strong Buy. This stock has a $29 average price target, matching Worthingtons. (See NTB stock analysis on TipRanks)Enviva (EVA)Last on our list is an energy company, Enviva. This company holds an interesting niche in an essential sector, producing green energy. Specifically, Enviva is a manufacturer of processed biomass fuel, a wood pellet derivative sold to power generation plants. The fuel is cleaner burning than coal an important point in todays political climate and is made from recycled waste (woodchips and sawdust) from the lumber industry. The companys production facilities are located in the American Southeast, while its main customers are in the UK and mainland Europe.The economic shutdowns imposed during the corona pandemic reduced demand for power, and Envivas revenues fell in 1H20, mainly due to that reduced demand. Earnings remained positive, however, and the EPS outlook for Q3 predicts a surge back to 45 cents in line with the strong earnings seen in the second half of 2019.Enviva has shown a consistent commitment to paying out its dividend, and in last quarter the August payment the company raised the payment from 68 cents per common share to 77 cents. This brought the annualized value of the dividend to $3.08 per share, and makes the yield 7.3%. Even better, Enviva has been paying out regular dividends for the past 5 years.Covering this stock for Raymond James is analyst Pavel Molchanov, who rates EVA as Outperform (i.e. Buy) and sets a $44 price target. Recent share appreciation has brought the stock close to that target.Backing his stance, Molchanov writes, Enviva benefits from an increasingly broad customer base, and there is high-visibility growth via dropdowns. In the context of the power sector's massive coal retirements including (as of September 2020) 34 countries and 33 subnational jurisdictions with mandatory coal phase-outs (To watch Molchanovs track record, click here.)Envivas Strong Buy consensus rating is based on 4 Buys and 1 Hold. Its share price, which has gained in recent sessions, is $42.60, and as mentioned, it has closed in on the $44.80 average price target. (See EVA stock analysis at TipRanks)To find good ideas for dividend stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Read the original post:
New Comprehensive CBD Alternative from Life Extension, Introducing Endocannabinoid Support, without THC or Hemp - Yahoo Finance

XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology |…

DetailsCategory: More NewsPublished on Friday, 16 October 2020 13:41Hits: 187

SAN DIEGO, CA, USA and FREISING, Germany I October 15, 2020 I Life Science Newswire Antlia Bioscience, Inc., a privately owned biopharmaceutical company located in San Diego, California, and XL-protein GmbH, a privately owned biopharmaceutical company located in Germany, are pleased to announce a strategic slliance using XL-protein's proprietary PASylation technology for plasma half-life extension to develop a novel, long-acting, peptide therapeutic treatment for chronic heart failure. Brian Johnson, Antlia Biosciences CEO commented, "chronic heart failure is a significantly unaddressed medical condition and a major public health concern. XL-protein's PASylation technology will allow us to safely and effectively translate our peptide into a meaningful therapeutic option for patients with chronic heart failure. "PASylation is an excellent biological solution for plasma-half extension of therapeutic peptides, and we believe that PASylation offers a simpler manufacturing process and superior pharmacological properties," commented Claus Schalper, CEO of XL-protein. "We are excited to work with Antlia Bioscience to further exploit the potential of our technology and to develop new therapeutic options for the treatment of chronic heart failure." Financial terms of the agreement have not been disclosed.

About PASylation Technology

'PASylation' involves the genetic fusion or chemical conjugation of a therapeutic protein or pharmaceutically active compound with a conformationally disordered polypeptide of defined sequence comprising the small natural amino acids Pro, Ala, and/or Ser. Due to the biophysical size effect, the typically rapid clearance via renal filtration of the original drug can be retarded by a factor 10-100, depending on the length of the PAS chain. PAS sequences are highly soluble while lacking charges, they are biochemically inert, non-toxic and non-immunogenic, they offer efficient recombinant protein production in a variety of biotechnological host organisms, and they show high stability in blood plasma but are biodegradable by intracellular proteases.

About XL-protein GmbH

XL-protein is a German biotech company commercializing its ground-breaking PASylation technology, which enables the design of biopharmaceuticals with extended plasma half-life and enhanced action. Based on a strong proprietary technology position, XL-protein focuses at the preclinical as well as clinical development of PASylated proteins in diverse disease areas. XL-protein is engaged in a growing number of partnerships with international pharmaceutical and biotech companies at various levels.

For more information, please visit:

About Antlia Bioscience, Inc.

Antlia Bioscience is a San Diego-based biotech developing groundbreaking peptide-based therapies to treat cardiovascular and metabolic diseases. Using PASylation and other state-of-the-art techniques, we turn promising peptides into groundbreaking therapies. We are driven to make a profound difference in the treatment of cardiovascular and metabolic diseases and believe that our efforts will result in a paradigm shift in how cardiovascular and metabolic diseases will be treated in the future.

For more information, please visit:

SOURCE: Antlia Bioscience

Read more here:
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology |...